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ABSTRACT 
 
Two studies were designed to evaluate the growth promoting and prebiotic 
properties of Yeast Cell Wall (YCW) containing mannanoligosaccharides (MOS) and 
guar gum galactomannans in starting broilers. In study one, the effects of different 
sources and concentrations of YCW-MOS and a blend from both the sources were 
investigated in starting broilers under both challenged (immune stress and Clostridium 
perfringens challenge) and unchallenged conditions through a series of 6 challenged and 
4 unchallenged experiments. Weekly body weights, feed consumption, and daily 
mortality were recorded. Each experiment was terminated after 3 weeks. YCW-MOS 
had no effect in the unchallenged birds. Pooled data analysis of challenged broilers 
revealed no effect of source of YCW-MOS. Both the products tested produced 
significant improvement in growth rate compare to the control birds. However, the blend 
of YCW-MOS showed approximately 15% improvement in growth rate with 10% 
reduction in feed conversion rate (FCR). The optimum dose of tested YCW-MOS 
products in starting broilers is determined to be 250 ppm. YCW-MOS additives 
produced increased body weight with a reduction in FCR and may be considered as 
alternatives to antibiotic growth promoters.  
In study two, newly hatched broiler chicks (24 pens, 6 replicates per treatment) 
were randomly distributed among four dietary treatments to evaluate the effects of guar 
gum galactomannans (GG) with and without Mannanase Guar® enzyme in starting 
broilers. Effects of dietary treatments (negative control, positive control-YCW product 
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Safmannan (YCW-S) at 500 ppm, GG at 500 ppm and GG at 500 ppm with enzyme 
(GGE) on growth, FCR, apparent ileal energy digestibility (AIED), intestinal 
histomorphology and microbial ecology were investigated. No significant differences 
were observed in body weight, feed conversion, mortality and productivity index. GG 
diets produced significantly reduced AIED, villus height, and increased crypt depth 
compared to the control. Broilers receiving GGE had overall intestinal villus height and 
AIED equal to YCW-S. Microbial patterns from the YCW-S and GGE treated broilers 
grouped together with a 95.6% similarity coefficient suggesting near identical microbial 
populations between these two groups. GG may have potential to consider as a prebiotic 
in starting broilers when used with an appropriate exogenous enzyme. 
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NOMENCLATURE 
YCW Yeast cell wall 
MOS Mannanoligosaccharides 
FOS Fructooligosaccharides 
GG Guar gum galactomannans 
GGE GG with Mannanase Guar® enzyme 
BW Body weight per bird 
WG Weight gain per bird 
FC Total feed consumption 
FCR Feed conversion ratio 
PI Productivity index 
MORT Mortality rate (%) 
NE Necrotic enteritis 
NEL Necrotic enteritis lesion score 
AIED Apparent ileal energy digestibility 
IBD Infectious bursal disease 
S Safmannan® 
P  Pronady® 
FR France 
BR Brazil 
CR Cedar Rapids 
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CHAPTER I 
 
INTRODUCTION 
 
 Antibiotics have been in use for centuries in one form or another. The previous 
century witnessed a dramatic improvement in human health with the development of 
antimicrobial drugs. Although most of these drugs are used to treat diseases in humans 
and animals, it is not uncommon to add antibiotics at very low levels to the animal feeds 
to improve growth rates. During the 1950’s, initial results with supplemental antibiotics 
suggested an overall improvement of 20-25% growth rate in poultry (Leeson and 
Summers, 2001). Antibiotic feed additives may influence performance by reducing the 
negative effects of highly variable disease conditions. Over the decades, several 
antibiotic resistant bacteria emerged posing a potential public health threat to humans. 
Emergence of resistant bacteria has been linked to the excessive use of sub-therapeutic 
doses of antimicrobial growth promoters. Based on several investigations, the European 
Union restricted the use of antibiotic growth promoters in animal husbandry since 
January 1, 2006. There is increasing public pressure to limit or withdraw the use of 
antimicrobial feed additives in the USA. Under such circumstances, to meet the food 
needs of increasing world population, animal protein production needs to be 
substantially increased. The pressing needs to be on developing potential alternatives for 
antibiotics in animal feeds. In the past two decades, several investigators evaluated the 
use of probiotics, prebiotics, synbiotics and organic acids as antibiotic alternatives in the 
animal agriculture. 
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Prebiotics are non-digestible food ingredients that beneficially affect the host by 
selectively stimulating the activity of one or more bacteria leading to better host health 
(Gibson and Roberfoid, 1995). Therefore, the primary characteristic of a prebiotic is to 
provide a substrate for beneficial gut microflora. Many of the non-digestible 
carbohydrates such as mannanoligosaccharides (MOS), fructooligosaccharides (FOS), 
and galactomannans have been investigated for prebiotic functions. Cereal grains are the 
primary energy source in animal feeds and contain about 80% carbohydrates (both starch 
and non-starch polysaccharides). All sources of potential energy are not completely 
digested by chickens. Monogastric animals lack enzymes to digest non-starch 
polysaccharides (NSP’s). The NSP’s make up to 10-30% of the carbohydrates present in 
cereals. Oligosaccharides and NSP’s are increasingly being investigated for this 
prebiotic activity. MOS and FOS inclusion at certain concentrations in poultry diets may 
improve performance, increase colonization of beneficial bacteria and reduce pathogenic 
bacteria. Yeast cell wall (YCW) derivatives consisting MOS are known to modulate 
immune response, and to influence intestinal microflora, thereby improving animal 
health under stress conditions. Research findings are suggesting that dietary inclusion of 
YCW in poultry diets may result in improved performance when subjected to immune 
stress or challenged with pathogens (Salmonella or C.perfringens). 
 Galactomannan, a non-starch polysaccharide naturally occurring in several plant 
legumes, is known to depress nutrient utilization by increasing the viscosity of intestinal 
contents. Adding exogenous enzymes to reduce the negative effects of some NSP’s is a 
common practice in poultry feeding. These enzymes improve digestibility of the 
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polysaccharides otherwise not digested by the host system. Galactomannan gum 
obtained from the plant legume guar may be considered for prebiotic functions. 
Conflicting results were reported on the effects of residual guar gum on layer and broiler 
performance. Guar gum galactomannan has a hypo-cholesteremic effect in rats and 
humans.  
Both oligosaccharides and non-starch polysaccharides have been proposed as 
prebiotic compounds to replace antimicrobial feed additives in animal husbandry. In this 
context, the objectives of this research are: 1) to investigate the effects of different 
sources and doses of YCW-MOS products on growth rate and feed conversion ratio in 
starting broilers; 2) to determine the best MOS-YCW product or combination of 
products among those; 3) to determine the optimal concentration or dose of YCW-MOS 
in starting broilers and 4) to investigate the effects of guar gum galactomannans with and 
without Mannanase Guar® on starting broiler performance, apparent ileal energy 
digestibility, intestinal histomorphology and microbial ecology. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
ANTIBIOTIC GROWTH PROMOTERS AND ANTIBIOTIC RESISTANCE 
Antibiotic growth promoters (AGPs) have been used extensively in animal 
feeding over the last few decades to increase growth rate and inhibit potential intestinal 
pathogens. The use of in-feed antibiotics is not without any risks or limitations. Sub 
therapeutic use of antibiotics in animal feeds resulted in emergence of resistant bacteria, 
which is a major problem of public health interest. Animals and humans share some 
common bacterial pathogens of public health interest. Widespread use of antibiotics in 
animals and humans plays a significant role in the emergence of antimicrobial drug 
resistant bacteria (Conly, 2002). There is well documented evidence (Bates et al, 1994; 
Coque et al, 1996; Van den Bogaard et al, 1997; Aarestrup et al, 2000; Van den Bogaard 
et al, 2000; Wegener, 2003; Gupta et al, 2004; Silbergeld et al, 2008) in the literature 
describing the link between excessive use of antimicrobials in animal agriculture and 
development of antimicrobial resistant bacteria of human interest.   
Bacteria are in a sense biochemical factories that respond to antibiotics with 
metabolic changes in an attempt to counter them. Bacteria use a kind of trial and error 
mechanism to create chemical responses to antibiotics. Once the right biochemical 
combination to resist the antibiotic in question develops, the new mutated strain will 
flourish. Generally it will take bacterial generations to develop resistance. In any animal 
system, when encountered with antibiotics, bacteria try to develop one or another 
mechanism to resist the action of the antibiotic. Bacterial resistance depends on different 
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mechanisms. Bacteria may be inherently resistant to an antibiotic (Wright, 2005; 
Yoneyama and Katsumata, 2006). Bacteria may exhibit resistance to the antibiotic by 
preventing antimicrobial access to their targets (Wright, 2005; Yoneyama and 
Katsumata, 2006), or by altering the target sites of antimicrobials (Rachakonda and 
Cartee, 2004), or by enzyme inactivation, which selectively target and inactivate the 
antibiotic (Yoneyama and Katsumata, 2006).  
Silbergeld et al, 2008 summarized the importance of agricultural antimicrobial 
drug use as a major driver of emerging antimicrobial resistance throughout the world for 
the following reasons - “It is the largest use of antimicrobials worldwide; much of the 
use of antimicrobials in agriculture results in sub-therapeutic exposures of bacteria; 
drugs of every important clinical class are utilized in agriculture; and human populations 
are exposed to antimicrobial-resistant pathogens via consumption of animal products as 
well as through widespread release into the environment”.  
Antibiotics are used in animal agriculture for therapeutic purposes, prophylactic 
purposes and also as growth promoters. The majority of the antibiotics are administered 
to animals with their feed or water as it is a practical way of giving medicines to large 
groups of animals. One obvious disadvantage associated with this process is that the 
sick, weaker animals with appetite loss consume smaller amounts of antibiotics than 
healthy animals. Antibiotic feed additives or growth promoters are given at sub-
therapeutic concentrations. In such cases there is a chance that bacteria become resistant 
to that particular antibiotic (Wegener, 2003) and later the resistant strains propagate. 
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The evolution of glycopeptide resistant enterococci (GRE) could be associated 
with the use of the avoparcin, glycopeptide antibiotic, as a growth promoter in food 
animals (Bates et al, 1994). This particular antibiotic (avoparcin) has never been 
approved for use in the USA but was fairly common in Australia and the European 
Union. Introduction of vancomycin and pristinamycin in swine production was 
associated with increased prevalence of resistant enterococci from human fecal samples 
in the Netherlands (Van den Bogaard et al, 2000). Several investigations on the 
development of resistant enterococci isolated from animal faeces and from food of 
animal origin, in multiple countries, confirmed the relationship between the use of 
antimicrobial growth promoters and high levels of resistance in enterococci (Coque et al, 
1996; Aarestrup et al, 2000; Van den Bogaard et al, 2002). 
Prophylactic treatment of poultry with fluoroquinolones resulted in increasing 
prevalence of ciprofloxacin-resistant Campylobacter species in the United States (Gupta 
et al, 2004). Their results proved that the source of fluoroquinolone-resistant 
Campylobacter infections was the consumption of poultry colonized with resistant 
strains rather than selection for Campylobacter in the human gut after clinical 
fluoroquinolone use to treat illness. Developing an animal reservoir of antimicrobial 
resistant bacteria is the major factor behind transmission of resistance to humans 
(Threlfall et al, 2000). Threlfall et al, (2000) also indicated that no resistance was 
observed in C. jejuni isolates tested from the poultry that had been treated 
therapeutically with enrofloxacin. These findings suggest that sub-therapeutic use of 
antimicrobials is the major reason in developing resistance. Unicomb et al, (2006) 
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reported that the relatively low rate of fluoroquinolone resistance in clinical isolates in 
Australia has been attributed to the fact that this drug was never used in animal 
agriculture. Use of virginiamycin as a growth promoter was linked to the carriage of 
Quinupristin-Dalfopristin-resistant enterococci in healthy humans (Van den Bogaard et 
al, 1997).  
Key determinants in transmission of the resistant bacteria to humans are rate of 
spread of resistant bacteria from animals to the environment, and rate of spread in the 
food production chain (Wegener, 2003). Bacteria from animals spread to the food 
products during slaughter and processing. Direct transmission of resistant enterococci 
between animals and farm workers has been reported by Van den Bogaard et al, 2002. A 
major determinant of developing resistance appears to be sub therapeutic antimicrobial 
doses.  
Based on several documentations that state that the use of antibiotic growth 
promoters in animal agriculture has led to the creation of a major food-animal reservoir 
of resistant bacteria, more importantly, further spreading of the resistant bacteria to 
humans by animal contact, food, or the environment, the European Union imposed a ban 
on all the Antibiotic Growth Promoters (since January 1, 2006) that belong to classes 
also used in human medicine (Wegener, 2003). In 2004, FDA approved withdrawal of 
the new animal drug application enrofloxacin for prophylaxis or growth promotion in 
poultry (Davidson, 2004). This was a major decision by the FDA and was the first 
occasion that a previously approved antimicrobial agent was removed from the U.S. 
market because of concerns about antimicrobial drug resistance. Although there are 
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some safety concerns, antimicrobial growth promoters are still used in animal feed in the 
United States.  
The World Health Organization recommends that antibiotic growth promoters 
should be prohibited in animal feeds. So, indiscriminate use of antibiotic growth 
promoters in animal production has been questioned because of the potential associated 
problems. The European Union prohibited the use of antibiotic growth promoters in 
animal industry since January 1, 2006 and there may likely be a ban on the use of growth 
stimulating antimicrobial agents in the United States in the near future. All of these 
concerns related with the therapeutic use of antibiotics in food producing animals 
stimulated the scientific community as well as producers to identify alternatives to sub-
therapeutic antibiotic use in the animal feeding. Some alternatives to antibiotics are 
probiotics, prebiotics, organic acids and various plant extracts (Griggs et al, 2005).  
PREBIOTICS AND YEAST CELL WALL PRODUCTS IN POULTRY 
 Antibiotic growth promoters have made major contributions to the profitability 
of animal agriculture. With increasing pressure to limit or withdraw AGPs from the feed, 
the incidence of intestinal disease may increase in the future. Researchers are looking for 
ways to enhance gut health as maintaining good gut health is critical for growth and 
productive performance of animal when no antibiotics are added to feed. Any of the non-
antibiotic growth promoters so far suggested in the literature cannot compensate 
completely for the absence of antimicrobial feed additives in the animal husbandry. A 
good alternative must not only improve the performance of the birds but also be 
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economical to add. For the past decade, extensive research has been conducted over the 
dietary supplementation of probiotics and prebiotics in poultry production.  
The concept of prebiotics was first introduced by Gibson and Roberfroid in 1995. 
They defined prebiotics as “a food ingredient that affects the functions of the body in a 
targeted manner so as to exert positive effects that may, in due course, justify health 
claims”. Generally prebiotics are non-digestible carbohydrates with beneficial effects on 
host health by selective stimulation of one or more bacteria in the GI tract (Gibson and 
Roberfroid, 1995). Oligosaccharides such as fructooligosaccharides (FOS) and 
mannanoligosaccharides (MOS) are the common prebiotic compounds extensively 
investigated as AGP alternatives in animal production (Ammerman et al, 1989; 
Kumprecht et al, 1997; Fukata et al, 1999; Spring et al, 2000).  
The available literature on the efficacy of oligosaccharide prebiotics in poultry 
feeding offers conflicting results. No difference in the performance was observed when 
turkeys were fed with different amounts of a commercial FOS preparation (Raftilose 
P95, Orafti, Belgium), containing 95% oligofructose (Juskiewicz et al, 2006), different 
concentrations of inulin (FrutafitInulin Tex, Holland) and a commercial MOS product 
(Bio-Mos®, Alltech Inc., Nicholasville, KY) (Stanczuk et al, 2005), whereas Sims et al, 
2004 reported an improved live weight in turkeys when fed with Bio-Mos® (Alltech 
Inc., Nicholasville, KY) supplemented diets.  
FOS inclusion in broiler diets has been demonstrated to decrease the levels of 
pathogenic bacteria such as E. coli and Salmonella and to enhance the levels of 
beneficial bacteria such as Lactobacillus and Bifidobacteria (Fakuta et al, 1999; Xu et al, 
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2003). Dose dependent effects of FOS (Meioligo-P®, Meiji Seika Kaisha Ltd., Tokyo, 
Japan) on average daily weight gain and feed conversion ratios in male broilers were 
reported by Xu et al. 2003.  
 The addition of YCW fractions in animal feeding has been extensively 
investigated for the past decade. Dietary inclusion of YCW, which has been derived 
from Saccharomyces cervisiae, in animal feeds resulted in improved performance in 
broilers (Spring et al, 2000; Baurhoo et al, 2007). The cell wall determines the shape and 
integrity of the yeast. The YCW consists of two layers – the inner layer is made of β-1,3- 
and β-1,6-glucans that is complexed with chitin and the outer layer is made up of 
mannoproteins (Osumi 1998) (Figure 2-1). The majority of the mannoproteins are 
covalently linked to the inner glucan layer and so referred to as the mannoprotein 
complex. Cell walls represent 26-32% of the dry weight of the cell in yeasts. 
Mannoproteins constitutes 40% of the cell dry mass, and are the major source of MOS in 
YCW, whereas beta-glucans account for 60% of the cell wall dry mass. Variation in the 
YCW composition was reported based on the strain origin and the commercial process 
applied to get the product (Aguilar-Uscanga and Francois, 2003). Therefore, the 
efficiency of YCW-MOS as feed additives may differ depending on the source to 
improve chicken performance. Beta-glucans, which are part of YCW, have a variety of 
biological properties, and are considered as immune modulator substances (Miura et al, 
1996). Improved humoral immune responses were observed in birds fed with MOS 
YCW (Cotter, 1997; Ghosh et al, 2012). 
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Figure 2-1: Structure and composition of yeast cell wall-mannoproteins are the 
primary source of the mannanoligosaccharides (Osumi 1998) 
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Bio-Mos® has been shown to decrease the prevalence of Salmonella, expressing 
type-1 fimbriae, in young broilers (Spring et al, 2000), to increase the intestinal villus 
height and counts of beneficial bacteria (Baurhoo et al, 2007). The increased villus 
height offers a larger surface for nutrient absorption and thereby is associated with 
increased growth rates. A meta-analysis study by Hooge, (2004) showed that dietary 
MOS may reduce the severity of coccidiosis infection in broilers. This analysis also 
reported an improved body weight, feed conversion ratio and decreased mortality. In 
addition, Bio-Mos® supplementation has been demonstrated to improve intestinal health 
benefits versus antibiotics (as shown with villus height and goblet cell number), to 
increase colonization of beneficial bacteria and to decrease pathogenic bacteria (Baurhoo 
et al, 2009), and to alter intestinal microbiota (Geier et al, 2009). Thus, MOS improves 
the structural integrity of the small intestine. Bio-Mos® and FOS (Fibrulose-F97, 
Cosucra Group Warcoing, Warcoing, Belgium), however, did not influence the 
performance of broilers under normal conditions (Baurhoo et al, 2009; Geier et al, 
2009).  
The gastro intestinal tract harbors a variety of microflora, consisting of both 
pathogenic and beneficial microbes. Pathogenic bacteria must adhere to the mucosal 
surfaces of the intestine for successful colonization. Targeting the bacteria attachment 
sites is an important strategy in reducing the pathogenic bacteria counts. Intestinal 
pathogens such as Salmonella and E. coli contain mannose specific type-1 fimbriae 
(adhesion organelles, which facilitate adherence to mucosal surface). Mannans in YCW 
act as high affinity ligand for bacteria. So, bacteria with mannose specific type-1 
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fimbriae bind to the MOS instead of binding to intestinal epithelium (Newman 1994). 
YCW-MOS serves as an alternate binding site for the bacteria and this MOS-bacteria 
complex can pass undigested through the gut (Spring et al, 2000). Reduced colonization 
of Salmonella and E. coli (Spring et al, 2000), E.coli and Campylobacter (Baurhoo et al, 
2009) were reported when Bio-Mos® was added to chicken diets. Morales-Lopez et al, 
(2010) suggested that the addition of YCW to the diets enhanced gut maturation by 
increasing the mucosal resistance to microbial translocation.  
There is an added advantage of using prebiotics in place of antimicrobial feed 
additives as prebiotics do not have any known side effects on the host system. 
Antibiotics not only kill the pathogenic bacteria but also eliminate beneficial bacteria, 
which are essential for maintaining good gut health. Overall, advantages of dietary 
supplementation of YCW-MOS include significant increase in weight gain and feed 
conversion; enhanced intestinal function, decreased mortality, improved colonization of 
beneficial bacteria and reduced counts of pathogenic bacteria. (Spring et al, 2000; Xu et 
al, 2003; Chen et al, 2007; Benites et al, 2008; Baurhoo et al 2009; Geier et al, 2009; 
Ghosh et al, 2012).  
SIGNIFICANCE OF NECROTIC ENTERITIS 
 The general health condition of the animal determines its performance, which in 
turn depends on several factors such as management, environment, nutrition, genetic 
potentiality, exposure to microbes etc. Health and nutrition are obviously interdependent. 
Maintaining good gut health is extremely important for wellbeing and productivity of the 
animal. A favorable intestinal environment coupled with the high availability of 
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nutrients are the key factors that influence the incidence of enteric pathogens such as C. 
perfringens. Economic losses associated with enteric pathogens have become a serious 
issue in the poultry industry as the use of controversial antibiotic growth promoters has 
declined resulting in increased prevalence of intestinal pathogens (Van Immerseel et al, 
2009).  
Necrotic Enteritis (NE) is an acute enteric disease associated with the gram 
positive, spore-forming anaerobic bacteria Clostridium perfringens. It is a widespread 
disease in broilers causing significant global economic losses to the poultry industry. 
Van der Sluis, (2000) estimated a total global financial loss of over 2 billion annually as 
a result of NE. Several predisposing factors like diet composition, exposure to stress, and 
the presence of coccidiosis contribute to the occurrence of NE in broilers. Diets rich in 
indigestible non-starch polysaccharides (wheat, barley, and oats) are known to increase 
intestinal viscosity and reduce nutrient digestibility (Branton et al, 1987; Craven 2000; 
Kocher, 2003) predisposing broilers to NE.  
NE in poultry was first described by Parish (1961). The infection may present as 
an acute clinical form characterized by decreased appetite, depression, diarrhea and 
necrosis of the intestines thus resulting in increased mortality (Ficken and Wages, 1997) 
or as a sub-clinical form causing damage to the intestinal mucosa leading to reduced 
nutrient absorption, decreased weight gain and impaired feed efficiency (Stutz and 
Lawton, 1984; Hofacre et al, 2003). The sub-clinical form of NE has become more 
prevalent in recent years where in no clinical symptoms are observed, but damaged 
intestinal mucosa causes production losses. 
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Controlling the incidence of NE is an important issue for the commercial poultry 
industry. Over the past several decades, sub-therapeutic use of antimicrobial feed 
additives has helped control the prevalence of NE. Without the use of antimicrobial feed 
additives, the incidence of NE is a major production concern (Kaldhusdal and Lovland, 
2000). Foodborne disease outbreaks caused by C. perfringens can often be traced back to 
poultry (Hook et al, 1996) making it not only an economically important disease, but 
also of potential public health threat.  
GUAR GUM GALACTOMANNANS AND EXOGENOUS ENZYMES 
Carbohydrates in poultry feeds 
 Carbohydrates are organic compounds which can be major sources of energy for 
poultry. All sources of potential energy are not completely digested by chickens. The 
amount of energy available to the bird is a deciding factor that determines growth rate 
and productive performance. Energy availability, in turn, depends on the digestibility of 
carbohydrates in GI tract. Complex carbohydrates are broken down into simple 
monosaccharides and then absorbed into the system to provide energy. Some 
carbohydrates are indigestible by gastric enzyme systems in chickens. The major factor 
influencing carbohydrate digestion is the content of indigestible polysaccharides in the 
diet. These indigestible polysaccharides are collectively called Non-Starch 
Polysaccharides (NSP’s, also referred to as crude fiber in the past).  
Polysaccharides consist of polymers of simple sugar units or monosaccharides. 
The monosaccharides are joined by a specific linkage called glycosidic bonds between 
the hemiacetal group of one sugar and the hydroxyl group of another sugar. The 
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common glycosidic bonds, α-1-4 and α-1-6 linkages found in starch, α-1-2 bond in 
sucrose, and β-1-4 link in lactose are cleaved by animal enzyme systems. Most other 
glycosidic bonds seen in NSP’s are unaffected by digestive systems and resist enzymatic 
action (Smits and Annison, 1996).  
Physicochemical properties of the NSP’s depend on the solubility of these 
compounds. NSP’s are responsible for increased viscosity of digesta, which can reduce 
solubility and utilization of nutrients. The importance of solubility and viscosity of 
NSP’s in the digestive tract, which influences nutrient digestion, has been described by 
Annison (1993). However, he also concluded that attributing antinutritive effects of 
NSPs solely to the increased viscosity of the intestinal contents may be too simplistic.  
Some commonly known NSP’s which have importance in poultry diets are 
raffinose in soybeans, beta-glucans in barley and arabinoxylans in wheat (Leeson and 
Summers, 2001). Among NSP’s, mannans occur in the form of galactomannan, 
glucomannan, and glucoronomanns in plants (Aman and Graham, 1990). The presence 
of galactomannas in some protein rich sources like guar meal and copra meal contribute 
anti-nutritive properties and limit usage of these ingredients in poultry feeds (Carre, 
2002). 
Guar gum galactomannans 
 Guar or Cluster bean, (Cyamopsis tetragonoloba) is a drought tolerant annual 
legume indigenous to the Indian subcontinent which is cultivated as a fodder and green 
manure crop to improve soil fertility. In the early 1950s U.S. commercial production of 
guar began in north Texas and southwestern Oklahoma. Guar seed consists of hull, germ 
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and a large endosperm, unlike the seeds of other legumes. The endosperm consists of 
primarily high molecular weight polysaccharides composed of galactomannans which 
are linear chains of (1→4)-linked β-D-mannopyranosyl units with (1→6)-linked α-D-
galactopyranosyl residues as side chains (Figure 2-2). The mannose: galactose ratio is 
approximately 2:1 (FAO publications 2006).  
The seeds are split, dehulled, milled, hydrolyzed and purified to obtain ground 
endosperm, the native guar gum, which has commercial value. Industrial applications of 
guar gum include but are not limited to the food industry as a thickening additive, textile 
printing, explosives, and oil/gas drilling industry (Whistler and Hymowitz, 1979). Guar 
gum, galactomannan NSP, is not digested in the digestive tract of monogastric animals. 
Dietary inclusion of pure guar gum at 1% did not produce any significant effect on 
histomorphology of the small intestine in piglets (Van Nevel et al, 2005). Considerable 
studies about guar gum have been mainly concentrated on its capacity to improve 
glucose tolerance levels, and lower blood cholesterol levels in rats (Blackburn and 
Johnson, 1981; Dario-Frias et al, 1998; Favier et al, 1998). 
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Figure 2-2: Structure of guar gum galactomannan-mannose backbone and 
galactose side chain (FAO, 2006) 
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Guar meal, a co-product of guar gum production, is a rich protein source and can 
be used in animal diets. However, use of guar meal in poultry feeding is limited by its 
adverse effects on feed intake, growth and production (Curl et al, 1986). Residual guar 
gum (galactomannan) present in guar meal is probably the major factor responsible for 
these reported adverse effects (Verma and Mcnab, 1984; Curl et al, 1986; Lee et al, 
2003). Other anti-nutrient compounds present in guar meal such as saponins, and 
possible trypsin inhibitors have been shown to cause decreased production (Curl et al, 
1986). Whether residual guar gum or saponin is primarily responsible for the negative 
effects on the animal performance is not clear. Several investigations reported adverse 
effects of β-galactomannan found in guar gum and guar meal (Ray et al, 1982; Curl et al, 
1986; Lee et al, 2003). Dietary inclusion of guar gum in poultry has been demonstrated 
to depress growth rate, increased intestinal viscosity associated with delayed gastric 
emptying, increased length and weight of intestinal tract, increased mortality rate and 
depressed nutrient utilization (Patel et al, 1980; Ray et al, 1982).  
On the other hand, there is some evidence suggesting benefits of feeding guar 
gum galactomannans to rats. Guar gum has been demonstrated to improve gut health 
through its prebiotic properties, in addition to its possible cholesterol lowering effect in 
rats (Dario-Frias et al, 1998; Favier et al, 1998; Moriceau et al, 2000). Adding guar gum 
to broiler diets has been reported to produce deleterious effects on performance when 
being fed at a higher concentration of 2% in 2 week old broilers (Daskiran et al, 2004). 
Daskiran et al, (2004) reported that the negative effects of guar gum supplementation 
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were partially alleviated by the inclusion of β-mannanase enzyme at 0.05%. 
Supplementing diets with mannanase enzyme resulted in improved feed utilization.  
Alleviating the adverse effects of NSP’s such as galactomannan is important to 
improve energy utilization. Interestingly, the addition of penicillin to poultry rations has 
been shown to reduce the negative effects associated with guar gum (Patel et al, 1980). 
As sub-therapeutic antibiotic usage in animal husbandry is no longer desired, 
supplementation of diets containing galactomannans with exogenous enzymes is a 
potential strategy to reduce anti-nutritive effects of the NSP’s. 
Exogenous enzymes 
 One potential strategy to alleviate the anti-nutritional properties of NSP’s is 
adding exogenous enzymes to the diet. These enzymes cleave NSP’s thus resulting in 
reduced viscosity and enhanced nutrient utilization by the birds. Supplementation of 
exogenous enzymes such as phytase (to improve phosphorus utilization) is common in 
poultry feeds. Other enzymes break down indigestible NSP’s thereby decreasing the 
viscosity of digesta and improving digestibility of feed (Bedfored et al, 1991). The use 
of exogenous enzymes in monogastric animals not only improves digestibility of feed 
ingredients but also reduces nutrient excreta output thereby offering a possible solution 
to some of the environmental issues associated with poultry production.  
The addition of exogenous enzymes in poultry diets has been well investigated 
and several commercial enzymes are available in the market. Exogenous enzyme 
supplementation is known to produce several benefits in poultry production such as 
improved feed conversion ratio, increase in growth rate, weight gain, and improved 
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digestibility and reduction in excreta output (Patel and McGinnis, 1985; Annison and 
Choct, 1991; Campbell and Bedford, 1992; Annison and Choct, 1993; Marquardt et al, 
1996; Choct, 2001; Daskiran et al, 2004).   
 The available literature to date has suggested beneficial effects of dietary 
prebiotic YCW-MOS, FOS, and the use of exogenous enzymes to improve performance 
in poultry. Residual guar gum galactomannans present in guar meal have been reported 
to show improved resistance to Salmonella infection in laying hens during molting 
(Zhang, 2005). To my knowledge, no study has evaluated the prebiotic effects of guar 
gum galactomannans on intestinal histomorphology and microbial ecology in broilers. 
 Nutrient intervention strategies are increasingly being considered to enhance gut 
health. One of the proposed dietary intervention strategies is the use of yeast cell wall 
containing mannanoligosaccharides (YCW-MOS). For this dissertation, six experiments 
were conducted to evaluate the effects of different concentrations and different sources 
of YCW on starting broiler performance using a “challenge model” in which birds are 
subjected to a Infectious Bursal Disease vaccine and Clostridium perfringens challenge. 
Based on these results, taking YCW-MOS product (Safmannan®) as positive control, a 
study was designed to evaluate the effects of dietary supplementation of  guar gum 
galactomannans with and without exogenous Mannanase Guar® (β-galactomannanse, 
1000 units/gram and cellulose 500 units/gram) enzyme on starting broiler performance 
in terms of growth, feed conversion, apparent ileal energy digestibility, intestinal 
histomorphology and microbial ecology.  
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The hypotheses of this research are: 1) Dietary supplementation of YCW-MOS 
in starting broilers improves performance under stress conditions; 2) Effectiveness of 
YCW-MOS depends on both source and concentration; and 3) The prebiotic properties 
of enzyme (β-galactomannanase) supplemented guar gum galactomannans are 
equivalent to those of YCW-MOS in starting broilers. 
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CHAPTER III 
EVALUATION OF YEAST CELL WALL MANNANOLIGOSACCHARIDE 
PRODUCTS IN STARTING BROILERS UNDER IMMUNE STRESS AND 
Clostridium perfringens CHALLENGE 
INTRODUCTION 
 Antimicrobial feed additives have been shown to have a tremendous effect on the 
growth rate of the animal, feed efficiency and reducing colonization of enteric pathogens 
(Stutz and Lawton, 1984; Leeson and Summers, 2001). New regulations on the 
prophylactic use of dietary antibiotic growth promoters in the European Union have 
accelerated the research to find alternate strategies to improve animal health. Dietary 
supplementation of probiotics and prebiotics is one possible strategy to enhance host 
health and to improve productive performance of animals. Probiotics are defined as “live 
microorganisms which, when administered in adequate amounts, confers health benefits 
on the host” (FAO/WHO, 2002). Several investigations have demonstrated that adding 
probiotic cultures to poultry diets has beneficial effects on host health by preventing 
colonization of enteric pathogens (Nurmi and Rantala, 1973; Weinack et al, 1979; 
Corrier et al, 1995; McReynolds et al, 2009). One limitation with the use of probiotics is 
that the probiotic organism needs to be established in the host intestine before exerting 
any beneficial effects on the host. When these probiotic products are withdrawn or no 
longer consumed, added bacterial populations are quickly washed out of the intestine 
(Bouhnik et al, 1992).  
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To overcome the limitations associated with the use of probiotic cultures, the 
concept of a prebiotic was proposed by Gibson and Roberfroid, (1995). Prebiotics are 
dietary substances utilized to improve growth rates of the host by targeting beneficial 
bacteria already colonizing the intestine. A prebiotic is defined as a nondigestible food 
ingredient that can be utilized by beneficial intestinal microflora thus leading to 
improved host health (Gibson and Roberfroid, 1995). Nondigestible carbohydrates (both 
oligosaccharides and polysaccharides) have been proposed as candidate prebiotics. 
Oligosaccharides are complex carbohydrates consisting of short chain (3-8) 
monosaccharides. Mannanoligosaccharides (MOS) and fructooligosaccharides (FOS) 
have both been investigated for prebiotic activities (Ammerman et al, 1989; Kumprecht 
et al, 1997; Fukata et al, 1999; Spring et al, 2000). With respect to monosaccharides, the 
ability of mannose to reduce Salmonella colonization in broilers is well documented 
(Oyofo et al, 1989a; Oyofo et al, 1989b; Oyofo et al, 1989c; Spring et al, 2000). 
Bio-Mos® (Alltech Inc., Nicholasville, KY) is a prebiotic-type product derived 
from yeast cell wall. In the previous literature, it is very common to describe yeast cell 
wall products as MOS, which is not technically correct. Yeast cell wall products contain 
MOS along with other manno proteins and β-glucans. In a meta-analysis study 
conducted by Hooge, (2004) MOS supplemented diets were reported to improve growth 
rate of broilers, with better feed conversion ratio and low mortality rate. Bio-Mos® has 
been shown to increase intestinal villus height and improved colonization of beneficial 
bacteria in broilers (Baurhoo et al, 2007). The increased villus height offers a larger 
surface for nutrient absorption and thereby is associated with increased growth rates. 
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Morales-Lopez et al, (2010) suggested that the addition of YCW to the diets enhanced 
gut maturation by increasing the mucosal resistance to microbial translocation.  
Supplementation of Bio-Mos® has been demonstrated to decrease colonization 
of enteric pathogenic bacteria such as Salmonella and E. coli (Spring et al, 2000), E.coli 
and Campylobacter (Baurhoo et al, 2009). Recent research findings also revealed that 
these YCW-MOS products may be effective in reducing the occurrence of NE lesions in 
broilers (Hofacre et al, 2003). Geier et al, (2009) reported that Bio-Mos® supplemented 
diets alter intestinal microbiota of broilers without affecting performance. YCW (AB 
Vista, Marlborough, Wiltshire, UK) treated diets exhibited better feed conversion ratio 
and improved humoral immune response against Newcastle disease in broilers (Ghosh et 
al, 2012). Ghosh et al, (2012) also reported that YCW supplemented diets were able to 
reduce intestinal Salmonella counts in 52-day-old broilers following oral challenge with 
Salmonella pullorum.  
Nutrient intervention strategies are increasingly being considered to enhance gut 
health. One of the proposed dietary intervention strategies is the use of yeast cell wall 
mannanoligosaccharides (YCW-MOS). Broilers encounter a variety of stress factors in 
the commercial environment. It is more likely that research experiments are carried out 
under ideal conditions. The application of results from research studies conducted under 
experimental conditions may not be appropriate to commercial practice. In this study, 
broiler performance was evaluated under both experimentally induced pathogen 
challenged and unchallenged conditions. 
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A series of six experiments were conducted to evaluate the effect of different 
concentrations and different sources of YCW-MOS on the performance of starting 
broilers in birds that were subjected to a compromised immune system induced by 
vaccination with an infectious bursal disease vaccine (live attenuated virus) followed by 
Clostridium perfringens challenge. The objectives of this study are 1) to investigate the 
effects of different sources and doses of YCW-MOS products on growth rate and feed 
conversion ratio in starting broilers; 2) to determine the best MOS-YCW product or 
combination of products among those; and 3) to determine the optimal concentration or 
dose of YCW-MOS in starting broilers.  
Hypotheses of this study are 1) Dietary supplementation of YCW-MOS in 
starting broilers improves performance under stress conditions; 2) Effectiveness of 
YCW-MOS depends on both source and concentration. 
MATERIALS AND METHODS 
Six experiments or trials were conducted to investigate different yeast products - 
Safmannan® derived from bakers yeast, Pronady® derived from brewers yeast and 
BioSaf® which is a live yeast product. All yeast products evaluated in this study were 
provided by Lesaffre feed additives (Lesaffre International Agricultural product division, 
Milwaukee, WI, USA). Product data sheets for all products evaluated in this study can 
be found in the appendix.  
Both challenged and unchallenged experiments were conducted at the same time, 
but in separate buildings during the first 4 trials. During trials 5 and 6, the unchallenged 
experiments were eliminated. In the challenged experiments, all birds were subjected to 
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immune stress and Clostidium perfringens challenge. All animal handling procedures 
were approved by Texas A&M University Animal Use Committee.  
General procedure for all experiments 
Common procedures followed in all the experiments are explained here with 
specific differences given under each experiment subheading. Ross 308 straight run 
broiler chicks used in this study were purchased from Sanderson farms, Bryan, TX. Feed 
and water were offered ad libitum with continuous lighting. A basal, industrial type corn 
soy based broiler starter diet was prepared (Table 3-1). The basal diet was divided into 
equal sized batches depending on the number of dietary treatments in that particular 
experiment and each batch supplemented with one of the YCW-MOS products at a 
specific concentration. Different dietary treatments investigated in each experiment are 
described below in separate sections. Dietary treatments were randomly assigned to pens 
such that each treatment was presented at least once for any given vertical row of pens 
within the Petersime battery brooders. Daily observations were made with regard to 
general flock condition, temperature, lighting, water, feed, and unanticipated events in 
the house. Pens were also checked daily for mortality. Pen averages were considered as 
the unit of measure for the performance phase of all experiments. Birds dying within the 
first 3 days of experiment were replaced as mortality occurring this early in any 
experiment was not considered treatment considered treatment related. Bird weights and 
feed consumption (grams) by pen were recorded at weekly intervals. 
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Table 3-1: Composition and nutrient content of broiler starter diets used in all 
experiments in the study 
 
INGREDIENT PERCENTAGE 
Corn 58.434 
Soybean meal 48% 34.493 
Dl-Met 98% 0.231 
Lysine HCl 0.177 
AV Fat, blended 2.755 
Limestone 1.561 
Mono-Dicalcium Phosphate 1.537 
Salt 0.512 
Trace minerals premix
1 
0.050 
Vitamin premix
2 
0.250 
CALCULATED NUTRIENT CONTENT (%)   
Protein 22.00 
ME (Kcal/Kg) 3050.00 
Crude fat 5.32 
Crude fiber 2.63 
Calcium 0.95 
AV Phosphate 0.71 
Sodium 0.22 
Methionine 0.56 
Lysine 1.31 
 
1 
Trace minerals premix added at this rate yields: 27.50 mg sulphur, 150 mg manganese, 
16.50 mg iron, 1.70 mg copper, 125.50 mg zinc, 0.25 mg selenium, 1.05 mg iodine, and 
0.84 mg molybdenum per kilogram diet. 
2 
Vitamin premix added at this rate yields: 11,023 IU vitamin A, 46 IU vitamin E, 3,858 
IU vitamin D3, 1.47 mg menadione, 2.90 mg thiamin, 5.80 mg riboflavin, 20 mg 
pantothenic acid, 0.55 mg biotin, 1.75 mg folic acid, 478 mg choline, 16.50 μg Vitamin 
B12, 46.00 mg niacin, and 7.20 mg pyridoxine per kilogram of diet. 
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Table 3-2: Study design for both the challenged and unchallenged experiments 
 Challenged* Unchallenged** 
Experiment Treatments
1 
Bird
2 
Birds per pen Vaccine
3 
C. perfringens challenge Treatments
1 
Bird
2 
Birds per pen 
Experiment 1 9 240 5 day 15 Day 18, 19, and 20 5 144 6 
Experiment 2 6 240 5 day 15 Day 18, 19, and 20 6 120 6 
Experiment 3 9 240 5 day 15 Day 18, 19, and 20 5 120 6 
Experiment 4 8 240 5 day 15 Day 18, 19, and 20 4 120 6 
Experiment 5 8 288 6 day 10 Day 16, 17, and 18 
------Eliminated------ 
Experiment 6 8 288 6 day 10 Day 16, 17, and 18 
 
1
Total number of dietary treatments in that particular experiment. 
2
Total number of birds in that particular experiment. 
3 
Birds in experiment 1 received Cocci-Vac and birds in rest of the experiments received infectious bursal disease vaccine. 
*Challenged group have 48 pens in all experiments and all birds received vaccine and challenge. 
**Unchallenged group have 24 pens in all experiments.
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Performance variables evaluated in this study were final body weight per bird 
(BW), weight gain per bird (WG), total feed consumption (FC), feed conversion ratio 
(FCR), Productivity Index (PI), and percent mortality rate (MORT). Productivity index 
was calculated using the following mathematical formula:   
PI = (100-MORT) x (BW/1000)/Bird age/FCR x 100 
The study design followed for both challenged and unchallenged is given in the Table  
3-2. 
Challenged experiments 
Birds were distributed among 48 pens in 2 Petersime battery brooder units. 
Number of dietary treatments, total number of birds, and age at which birds were 
challenged are illustrated in Table 3-2. The challenge model used to induce Necrotic 
Enteritis in starting broilers was adapted from McReynolds et al, (2004). 
Vaccine administration: A commercial infectious bursal disease (IBD) vaccine 
(Schering-Plough Animal Health, Millsboro, DE) was used as an immunosuppressant in 
all experiments except for the first experiment, in which Cocci-Vac® (Schering-Plough 
Animal Health, Millsboro, DE) was given. Birds were vaccinated with Cocci-Vac® by 
spraying the prescribed amount directly onto the feed provided to each pen of chickens. 
The IBD Vaccine was given at a level 10x the recommended dose of the manufacturer to 
immunocompromise the birds. Each bird in challenged group received the IBD vaccine 
via ocular route (eye drops). 
Clostridium perfringens challenge: Field isolates of C. perfringens (Georgia and Texas 
combined cultures) known to cause Necrotic Enteritis, originating from commercial 
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flocks were isolated, cultured separately, and then combined (McReynolds et al, 2004). 
The isolates were grown in thioglycollate medium for 12 h, and fresh inoculum was 
administered each day. The titration levels were approximately 1.0 x 10
8-9
. Each bird in 
challenged groups received C. perfringens challenge (2 mL administered by oral gavage 
to the crop) on days as illustrated in Table 3-2. 
Necrotic Enteritis lesion scoring: After 3 wk, all birds which did not previously die 
were euthanized and visually examined for signs of Necrotic Enteritis using a 0-4 
scoring system with zero being normal and 4 being the most severe form as described by 
Prescott et al, (1978): 0 = normal healthy intestine, no evidence of gross lesions; 1 = 
thin, friable small intestine, gray appearance; 2 = focal necrosis, ulceration, thin walled, 
gray appearance; 3 = sizable patchy necrosis, noticeable gas production in small 
intestine, small hemorrhage; 4 = severe extensive necrosis, large hemorrhages (as seen in 
birds died from NE), large amounts of gas in small intestine.  
Unchallenged experiments 
Birds were randomly distributed among 24 pens in one Petersime battery brooder 
unit. Number of dietary treatments and total number of birds, are illustrated in the Table 
3-2. Based on the data from 4 experiments, the unchallenged experiments were 
eliminated for experiments 5 and 6.  
Experiment 1  
 Two dietary additives studied in this experiment were YCW-MOS Safmannan® 
and Partially-hydrolyzed Safmannan (PH safmannan) at the rate of 0 (control), 125, 250, 
375, and 500 ppm for a total of 9 dietary treatments. A total of 240 broiler chickens were 
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randomly distributed 48 pens with 5 birds per pen in the challenged group (48 pens) and 
144 birds over 24 pens in with 6 birds per pen in the unchallenged group (24 pens). 
Dietary treatments are illustrated in Table 3-3. 
Statistics: For the challenge group, data were analyzed by ANOVA using the General 
Linear Model (GLM) as a 2 x 5 factorial based on 2 additives, 5 doses of each additive 
and also analyzed for the interaction of additive and dose. The unchallenged group 
(Safmannan only) data were analyzed by ANOVA with 5 treatments. Treatment means 
were separated using Duncan’s Multiple Range Test at a P value <0.05. 
Experiment 2 
 The YCW-MOS product, Pronady® (at 125 and 250 ppm), a live yeast extract 
concentrate, Biosaf® (at 1000 ppm), and a combination of Biosaf and Pronady (at 
1000+125 and 1000+250 ppm respectively) were evaluated in this experiment. There 
were 8 challenged replicates and 4 unchallenged replicates per treatment (Table 3-4).  
Statistics: The challenged group data were analyzed by ANOVA with 6 treatments. The 
unchallenged group data were analyzed by ANOVA with 6 treatments. To examine the 
effect of challenge, data were also analyzed as challenged group versus unchallenged 
group using ANOVA without including treatment in the model. Treatment means were 
separated using Duncan’s Multiple Range Test at a P value <0.05. 
Experiment 3 
Effects of dietary supplementation of two additives Pronady® and Safmannan® 
at a concentration of 0, 125, 250, 375, and 500 ppm were investigated in this experiment. 
Dietary treatments and replicates are described in Table 3-5. 
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Table 3-3: Experimental design for experiment 1 
No Additive 
Concentration 
(ppm) 
Challenged 
Replicates 
Unchallenged  
Replicates 
1 PH Safmannan
1 125 5 0 
2 PH Safmannan
1 250 5 0 
3 PH Safmannan
1 375 5 0 
4 PH Safmannan
1 500 5 0 
5 Control
 0 8 4 
6 Safmannan
2 125 5 5 
7 Safmannan
2 250 5 5 
8 Safmannan
2 375 5 5 
9 Safmannan
2 500 5 5 
 
1
PH Safmannan is Safmannan that had been treated by the manufacturer to partially 
hydrolyze the YCW. 
2
Safmannan is a YCW-MOS product derived from the bakers yeast. 
 
 
Table 3-4: Experimental design for experiment 2 
No Additive Concentration(ppm) 
Challenged 
Replicates 
Unchallenged 
Replicates 
1 No additive 0 8 4 
2 BioSaf
1 1000 8 4 
3 Pronady
2 125 8 4 
4 Pronady
1 250 8 4 
5 BioSaf+Pronady
3 1000+125 8 4 
6 BioSaf+Pronady
3 1000+250 8 4 
 
1
BioSaf is a live yeast (Saccharomyces cerevisiae) product used in the baking industry. 
2
Pronady is a YCW-MOS product derived from the yeast (Saccharomyces cerevisiae) 
used in the brewing industry. 
3
A combination treatment consisting of Pronady and Biosaf. 
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Table 3-5: Experimental design for experiment 3 
No Additive 
Concentration  
(ppm) 
Challenged 
Replicates 
Unchallenged  
Replicates 
1 Control
 0 8 4 
2 Pronady
1 125 5 5 
3 Pronady
1 250 5 0 
4 Pronady
1 375 5 5 
5 Pronady
1 500 5 0 
6 Safmannan
2 125 5 5 
7 Safmannan
2 250 5 0 
8 Safmannan
2 375 5 5 
9 Safmannan
2 500 5 0 
 
1
Pronady is a YCW-MOS product derived from the brewers yeast. 
2
Safmannan is a YCW-MOS product derived from the bakers yeast. 
 
 
Table 3-6: Experimental design for experiment 4 
No Additive 
Concentration 
(ppm) 
Challenged 
Replicates 
Unchallenged  
Replicates 
1 No additive 0 6 6 
2 Pronady
1 
125 6 0 
3 Pronady
1 
250 6 6 
4 Safmannan
2 
125 6 0 
5 Safmannan
2 
250 6 6 
6 Safmannan
2 
500 6 0 
7 P80S20
3 
125 6 0 
8 P80S20
3 
250 6 6 
 
1
Pronady is a YCW-MOS product derived from the brewers yeast. 
2
Safmannan is a YCW-MOS product derived from the bakers yeast. 
3
P80S20 is a blend of 80% of Pronady and 20% Safmannan. 
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Statistics: Data were analyzed by ANOVA using the GLM procedure as a 2 x 5 factorial 
based on two sources and 5 doses of each source and also for the interaction between 
source and dose. Treatment means were separated using Duncan’s Multiple Range Test 
at a P value <0.05. 
Experiment 4 
 Feed was supplemented with one of the two additives (Pronady® at 125 and 250 
ppm or Safmannan® at 125, 250 and 500 ppm). Two additional treatments consisted of a 
blend of 80% Pronady with 20% Safmannan at a total final concentration of 125 or 250 
ppm. Dietary treatments and replicates are illustrated in Table 3-6.  
Statistics: Data were analyzed by ANOVA using the GLM procedure, based on 8 
treatments and as an imbedded 2 x 2 factorial based on the two sources and 2 doses of 
each source, and also for the interaction of source and dose. Treatment means for Dose 
were separated using Duncan’s Multiple Range Test at a P value <0.05. 
Experiment 5 
 The basal diet was supplemented with one of two additives (Pronady® or 
Safmannan®) at the rate of 0, 125, 250, or 500 ppm. One additional treatment consisted 
of a blend of 50% Pronady and 50% Safmannan at a total final concentration of 134 
ppm. This experiment was terminated on day 20, one day earlier than previous 
experiments because of high mortality. Treatments and replicates are given in Table 3-7.  
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Table 3-7: Experimental design for experiment 5 
No Treatment Concentration (ppm) 
Challenged 
Replicates 
1 No additive 0 6 
2 Pronady
1 
125 6 
3 Pronady
1 250 6 
4 Pronady
1 500 6 
5 Safmannan
2 
125 6 
6 Safmannan
2 
250 6 
7 Safmannan
2 
500 6 
8 P50S50
3 
134 6 
 
1
Pronady is a YCW-MOS product derived from the brewers yeast. 
2
Safmannan is a YCW-MOS product derived from the bakers yeast. 
3
P50S50 is a blend of 50% of Pronady and 50% Safmannan. 
 
Table 3-8: Experimental design for experiment 6 
No Additive Concentration 
Challenged 
Replicates 
1 No additive 0 6 
2 FR Safmannan
1 250 6 
3 CR Pronady
2 250 6 
4 BR Pronady
3
  250 6 
5 FR S50+CR P50
4 250 6 
6 FR S50+BR P50
5 250 6 
7 CR P50+BR P50
6
 250 6 
8 FR S33.3+BR P33.3+CR P33.3
7 250 6 
 
1
FR Safmannan is a YCW-MOS product derived from the bakers yeast and 
manufactured in France.  
2
CR Pronady is a YCW-MOS product derived from the brewers yeast and manufactured 
in Cedar Rapids, Iowa, USA. 
3
BR Pronady is a YCW-MOS product derived from the brewers yeast and manufactured 
in Brazil. 
4
FR S50+CR P50 is a blend of 50% FR Safmannan and 50% CR Pronady. 
5
FR S50+BR P50 is a blend of 50% FR Safmannan and 50% BR Pronady. 
6
CR P50+BR P50 is a blend of 50% CR Pronady and 50% BR Pronady. 
7
 FR S33.3+BR P33.3+CR P33.3 is a blend of 33.3% FR Safmannan, 33.3% BR 
Pronady and 33.3% CR Pronady. 
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Statistics: Data were analyzed by ANOVA using the GLM procedure and as an 
imbedded 2 x 3 factorial based on the two sources and 3 doses of each source, and also 
for interaction of source and dose. Treatment means for Dose were separated using 
Duncan’s Multiple Range Test P value <0.05.  
Experiment 6 
This experiment investigated YCW-MOS products from various sources 
(different manufacturing plants) individually and in combination. All products were 
evaluated at 250 ppm. The basal diet was supplemented with one of the three additives 
or a blend (BR Pronady® from Brazil, CR Pronady® from Cedar Rapids, Iowa, USA; 
and FR Safmannan® from France) as indicated under the experimental design in Table  
3-8.  
Statistics: Data were analyzed by ANOVA using the GLM procedure based on 8 
treatments. Treatment means were separated using Duncan’s Multiple Range Test P 
value <0.05. 
Pooled data analysis: 6 challenged experiments 
 Data obtained from 6 challenged experiments were pooled and analyzed for the 
main effects of source (Control, Pronady®, Safmannan® and blend), dose (0, 125, 250, 
375 and 500) and for the interaction of source and dose using the GLM procedure by 
including experiment as a fixed factor. The Biosaf® 1000 ppm treatment from 
experiment 2 was excluded from the data and partially hydrolyzed safmannan treatment 
from experiment 1 was considered as a safmannan treatment. In all challenged 
experiments, data from broilers receiving any concentration of Safmannan, Pronady and 
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blend were evaluated for the effect of source and data from birds receiving 0, 125, 250, 
375 and 500 ppm of YCW-MOS additive were analyzed for the effect of dose. Variables 
analyzed were body weight per bird, weight gain per bird, total feed consumption, FCR, 
PI, and percent mortality.  
Pooled data analysis: 4 unchallenged experiments 
Data collected from the 4 unchallenged experiments were pooled and analyzed 
for the main effects of source (control, Pronady®, Safmannan® and blend) and dose (0, 
125, 250, 375 and 500 ppm) using the GLM procedure by including experiment as a 
fixed factor. Biosaf® 1000 ppm treatment from experiment 2 was excluded from the 
data. No significant differences were found in pooled data analysis of unchallenged 
experiments so the pooled unchallenged experiments are not discussed further. 
RESULTS 
Experiment 1 
 In the challenged group, there was no effect of dietary additive (Safmannan and 
PH Safmannan) on any of the variables tested (data not shown). There was no significant 
interaction between source and dose. However, dose had a significant beneficial effect at 
a concentration of 250 ppm or more on feed conversion ratio (FCR, feed intake to 
weight gain ratio), productivity index (PI) and percent morality (Table 3-9). When 
YCW-MOS was included at 375 ppm total percent mortality was significantly reduced 
compared to the control. No differences were observed in NE lesion score. In the 
unchallenged group, none of the treatments had significant effects on body weight, 
weight gain, feed consumption, FCR, PI, or mortality (Table 3-10).  
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Table 3-9: Effects of different doses of YCW-MOS supplementation on 
performance in the challenged group of broilers (21-day-old) from experiment 1 
 
Dose(ppm)  n BW* WG* FC* FCR PI NEL MORT(%) 
0 8 812 772 1313 1.70
b
 230
b
 0.27 12.5
b
 
125 9 826 785 1270 1.62
ab
 244
ab
 0.24 11.1
ab
 
250 9 858 816 1241 1.52
a
 270
a
 0.35 2.2
ab
 
375 9 841 800 1185 1.48
a
 271
a
 0.29 0.0
a
 
500 9 825 784 1210 1.55
a
 255
ab
 0.38 6.7
ab
 
PSEM**  17.64 17.62 44.13 0.05 10.84 0.11 3.72 
P value  0.48 0.50 0.30 0.04 0.06 0.88 0.09 
 
a,b
Means with no common superscript in the same row differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per 
bird). 
**Pooled standard error mean. 
 
 
 
 
Table 3-10: Effects of different doses of YCW-MOS supplementation on 
performance in the unchallenged group of broilers (21-day-old) from experiment 1 
 
Dose(ppm)  n BW* WG* FC* FCR PI MORT(%) 
0 4 779 734 1133 1.54 262 8.33 
125 4 770 729 1090 1.50 232 0.00 
250 4 737 696 1052 1.52 249 4.17 
375 4 787 746 1089 1.46 273 0.00 
500 5 796 755 1112 1.47 193 0.00 
PSEM**  30.60 30.66 39.48 0.04 30.52 5.39 
P value  0.70 0.70 0.69 0.65 0.36 0.50 
 
a,b
Means with no common superscript in the same row differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per 
bird). 
**Pooled standard error mean. 
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Table 3-11: Effects of different doses of YCW-MOS supplementation on performance in the challenged group of 
broilers (21-day-old) from experiment 2 
 
Treatment n BW* WG* FC* FCR PI NEL MORT(%)  
0 Control 8 642
c
 600
c
 1105
b 
1.55
a
 182
c
 0.88
b
 17.5
ab
 
1000 ppm BioSaf
1 8 745
b
 701
b
 1117
b 
1.49
ab
 223
b
 1.57
a
 27.5
a
 
125 ppm Pronady
2 8 844
a
 800
a
 1209
a 
1.42
ab
 267
a
 0.96
b
 10.0
b
 
250 ppm Pronady
 8 850
a
 807
a
 1190
a 
1.40
b
 275
a
 1.01
b
 7.5
b
 
1000 ppm BS+125 P
3 8 837
a
 794
a
 1151
a 
1.37
b
 275
a
 0.86
b
 2.5
b
 
1000 ppm BS+250 P
4 8 823
a
 780
a
 1195
a 
1.45
ab
 257
a
 1.22
ab
 10.0
b
 
PSEM**  20.96 20.98 45.44 0.05 11.49 0.17 5.29 
P value  <0.001 <0.001 <0.001 0.041 <0.001 0.062 0.030 
 
1
BioSaf is a live yeast (Saccharomyces cerevisiae) product used in the baking industry. 
2
Pronady is a YCW-MOS product derived from the yeast (Saccharomyces cerevisiae) used in the brewing industry. 
3
Diets supplemented with 1000 ppm BioSaf and 125 ppm Pronady. 
4
Diets supplemented with 1000 ppm BioSaf and 250 ppm Pronady. 
a,b
Means with no common superscript in the same row differ significantly (P<0.05). 
* Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**Pooled standard error mean. 
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Table 3-12: Effects of different doses of YCW-MOS supplementation on performance in the unchallenged group of 
broilers (21-day-old) from experiment 2 
 
Treatment n BW* WG* FC* FCR PI MORT(%) 
0 Control 4 701
a 
658
a 
958
b 
1.46
ab 
230
a
 0.0
a 
1000 ppm BioSaf
1 4 836
b 
793
b
 1216
a 
1.53
a 
258
b 
20.0
b 
125 ppm Pronady
2 4 862
b 
818
b
 1136
a 
1.39
b 
296
cd 
0.0
a 
250 ppm Pronady 4 887
b 
843
b
 1159
a 
1.37
b 
307
d 
0.0
a 
1000 ppm BS+125 P
3 4 848
b 
805
b
 1116
a 
1.38
b 
291
cd 
0.0
a 
1000 ppm BS+250 P
4 4 846
b 
802
b
 1197
a 
1.49
ab 
270
bc 
10.0
ab 
PSEM**  17.55 17.53 43.97 0.04 8.92 5.27 
P value  <0.001 <0.001 <0.001 0.069 <0.001 0.060 
 
1
BioSaf is a live yeast (Saccharomyces cerevisiae) product used in the baking industry. 
2
Pronady is a YCW-MOS product derived from the yeast (Saccharomyces cerevisiae) used in the brewing industry. 
3
Diets supplemented with 1000 ppm BioSaf and 125 ppm Pronady. 
4
Diets supplemented with 1000 ppm BioSaf and 250 ppm Pronady. 
a,b
Means with no common superscript in the same row differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**Pooled standard error mean.
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Experiment 2 
In this challenged experiment, Biosaf® (live yeast) and Pronady® (Yeast Cell 
Wall Product) effects were investigated at different dietary concentrations. All dietary 
treatments showed significant improvement in body weight, weight gain, and PI 
compared to the control (Table 3-11). Birds being fed with Pronady at 250 ppm 
displayed greater body weight, weight gain, higher feed consumption, better FCR, and 
higher PI compared to the control, Biosaf 1000 ppm or Pronady 125 ppm treatments. 
Live yeast (Biosaf) doesn’t seem to be effective against C. perfringens challenge when 
compared to Pronady even though it was significantly better from the control with 
respect to body weight, weight gain and productivity index.  
Results for the unchallenged group are shown in Table 3-12. All dietary 
treatments resulted in better performance compared to the control. Without challenge, 
Biosaf resulted in greater body weight but not without an increase in FCR, which is not 
desirable. Overall, dietary supplementation of Pronady at 250 ppm produced better 
results even in the unchallenged group. Significant improvements were observed in 
unchallenged group for the production variables FCR, PI and percent mortality 
compared to the challenged group (Table 3-13).  
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Table 3-13: Effects of challenge on 21-day-old broiler performance receiving YCW-
MOS supplemented diets in experiment 2 
 
 n BW* WG* FC* FCR PI MORT(%) 
Challenged 48 790 747 1145 1.45
a
 247
b
 12.5
a
 
Unchallenged 24 830 787 1130 1.36
b
 275
a
 5.0
b
 
PSEM**  15.31 15.28 23.49 0.02 7.36 2.66 
P value  0.071 0.071 0.669 0.006 0.007 0.05 
 
a,b
Means with no common superscript in the same column differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per 
bird). 
**Pooled standard error mean. 
 
 
 
Table 3-14: Effects of source and dose of YCW-MOS supplementation on 
performance in the challenged group of broilers (21-day-old) from experiment 3 
 
 n BW* WG* FC* FCR PI NEL MORT 
Source         
Safmannan
1 
24 811 772 1411 1.81 216 1.15 26.95 
Pronady
2 
23 799 760 1317 1.74 225 1.16 20.00 
PSEM**  12.81 12.76 62.88 0.08 9.56 0.10 4.02 
Dose         
0 8 697
b 
658
b 
1185 1.80 189 0.92 15.00 
125 ppm 10 839
a 
800
a 
1417 1.78 230 1.41 26.00 
250 ppm 10 805
a 
766
a 
1396 1.82 217 1.24 28.00 
375 ppm 10 843
a 
804
a 
1536 1.89 215 1.13 32.00 
500 ppm 9 821
a 
783
a 
1233 1.57 249 0.99 13.33 
PSEM**  20.33 20.24 99.82 0.12 15.17 0.17 6.39 
P value         
Source  0.485 0.486 0.362 0.622 0.614 0.919 0.270 
Dose  0.0001 0.0001 0.1180 0.5020 0.1510 0.3130 0.1770 
Sourse*Dose  0.760 0.742 0.553 0.579 0.686 0.759 0.728 
 
1
YCW-MOS product from bakers yeast. 
2
YCW-MOS product from brewers yeast. 
a,b,c
Means for main effects in a column with no common superscript differ (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per 
bird). 
**Pooled standard error mean. 
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Experiment 3 
In the challenged group, no significant effects of source (Pronady® and 
Safmannan®) were detected (Table 3-14). There was no significant interaction between 
source and dose. However, dose significantly improved body weight and weight gain at 
all the concentrations tested (Table 3-14). No significant differences were detected for 
feed intake, FCR, PI, NEL and percent mortality (Table 3-14). No significant differences 
were observed for any of the production variables in the unchallenged group of birds 
(data not shown). 
Experiment 4 
 
There were no significant differences detected for any of the parameters 
measured in this experiment, either in the challenged (Table 3-15) or the unchallenged 
(Table 3-16) groups. No significant differences were observed in 2 x 2 factorial analyses 
(Pronady and Safmannan at 125 and 250 ppm) (data not shown). No significant interaction 
between source and dose was detected. 
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Table 3-15: Effects of different YCW-MOS product supplementation on performance in the challenged group of 
broilers (21-day-old) from experiment 4  
 
Treatment n BW* WG* FC* FCR PI MORT(%) NEL 
0 6 880 836 1387 1.68 263 6.67 1.22 
Pronady125
1 6 937 893 1232 1.38 324 3.33 0.90 
Proandy250
1 6 914 871 1267 1.46 302 0.00 0.86 
Safmannan125
2 6 906 862 1275 1.48 296 0.00 1.19 
Safmannan250
2 6 968 924 1350 1.47 320 3.33 1.07 
Safmannan500
2 6 928 884 1351 1.53 293 0.00 1.01 
P80S20-125
3 6 902 858 1234 1.44 301 0.00 1.32 
P80S20-250
3 6 940 895 1301 1.45 310 0.00 1.06 
PSEM**  26.15 26.22 72.4 0.08 17.54 2.23 0.24 
P value  0.390 0.400 0.722 0.420 0.236 0.290 0.879 
 
1
 Diets containing Pronady (YCW-MOS product derived from the brewers yeast) at a given concentration. 
2 
Diets containing Safmannan (YCW-MOS product derived from the bakers yeast) at a given concentration. 
3 
Diets containing a blend of Pronady 80 and Safmannan 20 (blend of 80% of Pronady and 20% Safmannan) at a given final 
concentration. 
*Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**Pooled standard error mean. 
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Table 3-16: Effects of different YCW-MOS product supplementation on performance in the unchallenged group of 
broilers (21-day-old) from experiment 4 
 
Treatment n BW* WG* FC* FCR PI MORT(%) 
Control 6 911 869 1273 1.47 297 0.00 
Pronady250
1 6 910 867 1276 1.48 295 0.00 
Safmannan250
2 6 872 828 1232 1.49 280 0.00 
P80S20-250
3 6 885 842 1216 1.45 291 0.00 
PSEM**  30.96 30.96 34.54 0.02 13.11 0 
P value  0.408 0.408 0.536 0.645 0.354 0 
 
1
 Diets containing Pronady (YCW-MOS product derived from the brewers yeast) at a given concentration. 
2 
Diets containing Safmannan (YCW-MOS product derived from the bakers yeast) at a given concentration. 
3 
Diets containing a blend of Pronady 80 and Safmannan 20 (blend of 80% of Pronady and 20% Safmannan) at a given final 
concentration. 
*Final body weight, weight gain and total total feed consumption are given in grams (per bird). 
**Pooled standard error mean. 
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Experiment 5 
Broilers receiving the combination treatment (50:50 blends of Pronady® and 
Safmannan® at a final concentration of 134 ppm) weighed significantly more than those 
of other dietary treatments evaluated in this experiment (Table 3-17). FCR and PI were 
also significantly better for this combination treatment. However, no difference in feed 
consumption was detected. This particular population of birds was significantly smaller 
compared to those of other experiments. They most likely came from lightweight broiler 
breeders just entering production. In this experiment, challenge was accelerated to see if 
it might reduce the variability (randomness) associated with the NE lesion scoring. The 
accelerated challenge did not lower the variation of the NE lesion scoring. Mortality was 
quite a bit higher than normal in this experiment, so it was decided to terminate the 
experiment 1 day early (day 20 Versus 21). There was some visual evidence of lesion 
healing, but this could not be related to any particular treatment. No significant 
differences were detected by the 2 x 3 factorial analysis (Pronady and Safmannan at 125, 
250 and 500 ppm) except for productivity index (data not shown). Safmannan has 
significantly higher productivity index compared to Pronady. 
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Table 3-17: Effects of YCW-MOS supplementation on performance in the challenged group of broilers (20-day-old) 
from experiment 5 
 
Treatment n BW* WG* FC* FCR PI MORT(%) NEL 
Control 6 722
bc
 678
bc
 1029 1.52
a 
220
c
 13.89 1.16 
Pronady125
1 6 751
abc
 707
abc
 1023 1.45
ab 
247
abc
 19.45 1.36 
Pronady250
1 6 718
c
 674
c
 1017 1.52
a 
221
c
 19.44 1.48 
Pronady500
1 6 747
abc
 704
abc
 1056 1.50
ab 
231
bc
 8.33 1.72 
Safmannan125
2 6 786
abc
 742
abc
 1079 1.45
ab 
250
abc
 22.22 1.29 
Safmannan250
2 6 794
ab
 750
ab
 1088 1.45
ab 
261
ab
 16.67 1.23 
Safmannan500
2 6 745
abc
 701
abc
 1030 1.47
ab 
242
abc
 13.89 1.67 
P50S50
3 6 819
a
 775
a
 1103 1.42
c 
269
a
 25.00 1.23 
PSEM**  23.02 23.00 30.77 0.02 11.42 7.27 0.24 
P value  0.035 0.036 0.337 0.102 0.103 0.805 0.621 
 
1 
Diets containing Pronady (a YCW-MOS product derived from the brewers yeast) at a given concentration. 
2 
Diets containing Safmannan (a YCW-MOS product derived from the bakers yeast) at a given concentration. 
3
P50S50 is a blend of 50% of Pronady and 50% Safmannan with a final concentration of 134 ppm. 
a,b,c 
Means within a column with no common superscript differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**Pooled standard error mean. 
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Table 3-18: Effects of YCW-MOS supplementation on performance in the challenged group of broilers (21-day-old) 
from experiment 6 
 
Treatment** n BW* WG* FC* FCR PI MORT(%) 
Control 6 819
a
 773
a 1207 1.57
b 
194 22.2 
FR Safmannan
1 6 841
ab
 796
ab 1202 1.52
b
 197 27.7 
CR Pronady
2 6 844
ab
 798
ab
 1202 1.51
b
 233 13.9 
BR Pronady 
3 6 856
ab
 811
ab
 1238 1.53
b
 224 16.6 
FR S50+CR P50
4 6 923
b
 877
b
 1206 1.38
a
 267 16.7 
FR S50+BR P50
5 6 891
ab
 846
ab
 1237 1.46
ab
 226 22.2 
CR P50+BR P50
6 6 897
ab
 851
ab
 1250 1.47
ab
 235 19.4 
FR S33.3+BR P33.3+CR P33.3
7 6 892
ab
 846
ab
 1308 1.55
b
 202 27.8 
PSEM***  28.21 28.24 44.93 0.04 24.7 7.53 
P value  0.170 0.178 0.708 0.081 0.459 0.853 
 
1
FR Safmannan is a YCW-MOS product derived from the bakers yeast and manufactured in France.  
2
CR Pronady is a YCW-MOS product derived from the brewers yeast and manufactured in Cedar Rapids, Iowa, USA. 
3
BR Pronady is a YCW-MOS product derived from the brewers yeast and manufactured in Brazil. 
4
FR S50+CR P50 is a blend of 50% FR Safmannan and 50% CR Pronady. 
5
FR S50+BR P50 is a blend of 50% FR Safmannan and 50% BR Pronady. 
6
CR P50+BR P50 is a blend of 50% CR Pronady and 50% BR Pronady. 
7
 FR S33.3+BR P33.3+CR P33.3 is a blend of 33.3% FR Safmannan, 33.3% BR Pronady and 33.3% CR Pronady. 
a,b 
Means within a column with no common superscript differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**All the dietary treatments were supplemented at a concentration of 250 ppm. 
***Pooled standard error mean.
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Experiment 6 
YCW-MOS products manufactured in different plants and their combinations 
were tested in this experiment. Dietary treatments with the FR S50+CR P50 combination 
performed significantly better than the control with greater body weight, weight gain and 
low FCR (Table 3-18). Performance variables tested are shown in Table 3-18. 
Pooled data analysis 
 Pooled data analysis from the challenged experiments revealed that the source 
and dose of YCW-MOS additive had significant beneficial effects on the performance 
(Table 3-19). No significant differences were detected between the two sources 
(Pronady® and Safmannan®) of YCW-MOS. There was no significant interaction 
between source and dose. Safmannan and Pronady performed significantly better 
compared to the control and resulted in an overall improvement of 10% growth rate with 
no difference in FCR. The blend (mix of Pronady and Safmannan) produced better 
effects with an improvement of more than 15% growth rate, more than 10% reduction in 
FCR, greater feed consumption and higher productivity index compared to the control. 
All doses of YCW-MOS displayed significant improvement compared to the control and 
produced a greater body weight with significantly lower FCR. A dose effect of YCW-
MOS on body weight was demonstrated in Figure 3-1, with a peak response close to 250 
ppm and a decline in body weight above 300 ppm. No significant differences in 
mortality rate were observed.  
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Table 3-19: Effects of source and dose of YCW-MOS product on performance in 
21-day-old broilers (Pooled data from all 6 challenged experiments excluding the 
Biosaf treatment from experiment 2) 
 
 n BW* WG* FC* FCR PI MORT(%) 
Source        
Control 42 756
c 
713
c 
1160
b 
1.63
a 
199
c 
16.03 
Safmannan
1 
98 841
b 
799
b 
1206
ab 
1.51
ab 
242
b 
14.49 
Pronady
2 
78 829
b 
786
b
 1162
b 
1.48
bc 
245
ab 
14.36 
Blend
3 
58 877
a 
832
a 
1217
a 
1.46
c 
261
a 
14.2 
PSEM**  8.22 8.21 18.62 0.02 5.94 1.96 
Dose        
0 36 745
c 
703
c 
1152 1.64
a 
200
c 
15.00 
125 37 844
a 
801
a 
1182 1.48
b 
259
a 
13.43 
250 71 858
a 
814
a 
1212 1.49
b 
244
ab 
15.69 
375 19 842
a 
802
a 
1206 1.50
b 
222
b 
16.84 
500 113 809
b 
767
b 
1159 1.51
b 
240
ab 
12.16 
PSEM**  10.48 10.48 23.77 0.02 7.57 2.50 
P value        
Source  0.053 0.055 0.333 0.209 0.144 0.775 
Dose  0.427 0.435 0.231 0.706 0.762 0.463 
Sourse*Dose  0.432 0.436 0.538 0.600 0.299 0.515 
 
1
YCW-MOS product from bakers yeast. 
2
YCW-MOS product from brewers yeast. 
3
Mix of Safmannan and Pronady. 
*Final body weight, weight gain and total feed consumption are given in grams (per 
bird). 
**Pooled standard error mean. 
a,b,c
Means for main effects in a column with no common superscript differ (P<0.05). 
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Figure 3-1: Effect of YCW-MOS dose on body weight in 21-day-old broilers 
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DISCUSSION 
 This study indicated that dietary inclusion of YCW-MOS improved body weight, 
weight gain, and productivity index and reduced FCR in starting broilers under immune 
stress and Clostridium perfringens challenge. The improved weight gain in 
supplemented broilers is likely due to the prebiotic functionality of YCW-MOS, which 
has been reported to promote colonization of beneficial bacteria, improve intestinal 
integrity, and enhance immune functions (Ferket et al, 2002; Loddi et al, 2002; Yang et 
al, 2008; Ghosh et al, 2012). In this study, no difference in production parameters were 
observed between the two sources of YCW-MOS product tested (Safmannn® – The 
baker’s yeast product and Pronady® – The brewer’s yeast product), however the blended 
product (mix of safmannan and pronady) produced a greater body weight with no 
difference in FCR compared to the individual YCW products. There is a distinct 
possibility that the blended products are performing better than the unblended products. 
This may be due to a “broader” immune response from the mannan proteins present in 
the YCW-MOS products (the outer surface of YCW contains mannoproteins, which are 
covalently linked to β-glucans on the inner layer). Even though YCW-MOS products 
tested in this study were derived from the same yeast species, Saccharomyces cerevisiae, 
bakers yeast and brewers yeast likely have different mannan proteins, stimulating a 
broader immune response.  
It has been reported that YCW-MOS products did not produce consistently 
beneficial results on broiler production performance. The current results were in 
accordance with some previous reports and contradictory to other reports. Gao et al, 
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(2008) described that oligosaccharides supplemented in diets increased feed intake in 
broilers by improving appetite. Increased feed consumption eventually results in greater 
body weight gain and can reduce FCR, which support the findings of the current study. 
The current study also revealed that the optimum level of YCW-MOS products 
(LeSaffre feed additives, Milwaukee, WI) in starting broiler diets is approximately 250 
ppm. It was reported that diets supplemented with Safmannan® at a rate of 500 ppm did 
not affect the body weight, FCR or mortality in starting, growing or finishing broilers 
under normal conditions (Benites et al, 2008). In the unchallenged group of present 
study, YCW-MOS produced no significant improvement in growth rate.  
In contrast to the results presented here, Bio-Mos® at 1000 ppm in starter feed 
and 500 ppm in grower and finisher feeds improved body weight without any change in 
FCR (Benites et al, 2008). Bio-Mos® (Alltech Inc., Nicholasville, KY) is a yeast cell 
product derived from brewers yeast. A commercial YCW product (Lesaffre feed 
additives, Marquette-Lez-Lille, France) supplemented at 500 ppm improved FCR in corn 
based diets with no effect in wheat based diets in 2-week-old broilers (Morales-Lopez et 
al, 2010). Geier et al, (2010) reported that Bio-Mos at 0.5% (5000 ppm) in wheat based 
diets did not influence performance, but did alter intestinal microbiota in finishing 
broilers.   
Very limited research is available on the effects of prebiotics on C. perfringens 
infection in broilers. In vivo studies in mammals and in vitro models revealed that FOS 
in diets resulted in significantly fewer C. perfringens bacteria in the intestinal tract 
(Gallaher et al, 1996; Swanson et al, 2002). In the present study, supplementation of 
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YCW-MOS in diets resulted in improved performance under immune stress and C. 
perfringens challenge in starting broilers. In a study by Thanissery et al, (2010) dietary 
supplementation of NuPro® yeast extract (Alltech Inc., Nicholasville, KY) at 2000 ppm 
was shown to reduce the intestinal levels of C. perfringens and the intestinal lesions 
associated with NE under C. perfringens challenge. On the contrary, Hofacre et al, 
(2003) reported that in an experimental challenge model, dietary supplementation of 
Bio-Mos® at 2000 ppm had no significant effect on mortality caused by NE, growth rate 
or FCR in 6-week-old broilers.  
Immunosuppressed chickens are more likely to develop NE. Successful 
conditions may compromise the immune system and predispose the birds to NE 
(McDevit et al, 2006). Lesion scores were higher when an IBD vaccine was 
administered prior to challenge (Gholamiandehkordi et al, 2007). In the present study, 
IBD vaccine was given to birds in the challenged experiments. However, no significant 
differences in lesion scores were observed. YCW-MOS products act as immune 
modulating substances which may stimulate gut associated and systemic immunity by 
acting as a non-pathogenic microbial antigen, giving an adjuvant-like effect (Ferket et al, 
2002). This suggests that the YCW-MOS blend may stimulate a broader immune 
response. 
Inconsistent results were noted with regard to lowering mortality rate in the 
present study. In experiments one and two, YCW-MOS product reduced mortality rate 
compared to the control group. No differences in mortality rate were observed in the 
pooled data analysis from all experiments. Hooge (2004) suggested that the morality 
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lowering effect of MOS was its strongest attribute and this effect was significantly 
greater in this regard compared to antibiotic growth promoters. The findings of this 
research do not necessarily support this conclusion.  
In a meta-analysis conducted by Hooge, (2004) it was revealed that broiler diets 
containing “MOS” improved final body weight by 1.75% compared to the negative 
control diets. It is likely that the “MOS” described in Hooge’s meta-analysis not all pure 
mannanoligosaccharides as it was fairly common in earlier literature to describe 
heterogenous YCW products as MOS which is not technically correct. In 2010, The 
Texas State Chemist forbid the characterization of YCW additives as MOS since they 
are actually a mixture of many things in addition to the MOS and mannoproteins. In the 
current study, pooled data analysis indicated that broilers receiving the blend of 2 YCW-
MOS products showed an overall improvement of 15% in body weight at 21 days of age 
compared to broilers receiving negative control diets. Hooge, (2004) also reported that 
broiler diets containing “MOS” resulted in an approximately 2% decrease in FCR at 42 
days of age. This finding is also in somewhat agreement with the present study, where 
broiler diets supplemented with blend of YCW-MOS decreased FCR by more than 10% 
in 21-day-old broilers. Hooge, (2004) reported no significant differences in final body 
weight or FCR among broilers receiving diets supplemented with either “MOS” or 
antibiotic growth promoter. Hooge, (2004) also suggested that the optimal “MOS” levels 
in broiler diets were 0.2% (2000 ppm) from 0 to 7 days; 0.1% (1000 ppm) from 7 to 21 
days and 0.05% (500 ppm) from 21 to 42 days to achieve improved body weight with 
 
57 
 
reduced FCR. However, this study suggests a blend of YCW-MOS with a concentration 
of approximately 250 ppm (0.025%) in starting broilers (0-21 days) is the optimum dose. 
 Dietary supplementation of YCW-MOS products produced growth improvement 
in starting broilers under challenge conditions. The YCW-MOS products may be 
considered as potential alternatives to traditional antibiotic growth promoters in poultry 
feeds. 
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CHAPTER IV 
 
EFFECTS OF GUAR GUM GALACTOMANNANS WITH AND WITHOUT 
MANNANASE GUAR® ENZYME ON STARTING BROILER PERFORMANCE, 
APPARENT ILEAL ENERGY DIGESTIBILITY, INTESTINAL 
HISTOMORPHOLOGY AND MICROBIAL ECOLOGY 
INTRODUCTION 
Non Starch Polysaccharides (NSP’s), naturally occurring in many foods, affect 
the digestion and absorption of other nutrients. NSP’s are anti-nutritive compounds 
known to cause decreased performance of the birds by adversely affecting nutrient 
utilization. Addition of NSP’s to broiler diets adversely affects nutrient digestibility 
(Choct and Annison, 1992a), which has been associated with an increase in intestinal 
viscosity (Choct and Annison, 1992b). The increased viscosity effectively slows down 
passage of digesta, increasing digesta retention time. Even though digesta retention time 
is increased, increased viscosity affects the action of enzymes on substrates, thus 
decreasing actual available nutrients (Smits and Annison, 1996). Some feed ingredients, 
like guar meal and copra meal, are of only limited use in poultry because of the natural 
occurrence of NSPs. To alleviate the antinutritive effects of NSPs, exogenous enzymes 
can be added to the feed. 
The endosperm of guar seed consists primarily of high molecular weight 
polysaccharides composed of galactomannans, which are linear chains of (1→4)-linked 
β-D-mannopyranosyl units with (1→6)-linked α-D-galactopyranosyl residues as side 
chains. The mannose:galactose ratio is approximately 2:1 (FAO publications, 2006). 
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Guar gum, galactomannan NSP, is not digested in the digestive tract of monogastric 
animals. Guar meal, a co-product of guar gum production, is a rich protein source and 
can be used in animal feeds. However, use of guar meal in poultry feeding is limited by 
its adverse effects on feed intake, growth and production (Curl et al, 1986). Residual 
guar gum (galactomannan) present in guar meal is probably the major factor responsible 
for reported adverse effects (Verma and Mcnab, 1984; Curl et al, 1986; Lee et al, 2003). 
Most studies with guar gum have concentrated on its capacity to improve glucose 
tolerance levels and to lower blood cholesterol levels in rats (Blackburn and Johnson, 
1981; Dario-Frias et al, 1998; Favier et al, 1998) and to exhibit immunostimulatory 
functions in rats (Dario-Frias et al, 1998; Moriceau et al, 2000). Inclusion of 1% guar 
gum in piglet diets did not have any effect on histomorphology of the small intestine in 
piglets (Van Nevel et al, 2005).  
Adding 2% guar gum to broiler diets has been reported to produce deleterious 
effects on broiler performance (Daskiran et al, 2004). Dietary inclusion of guar gum in 
poultry has been demonstrated to depress growth rate, increase intestinal viscosity 
associated with delayed gastric emptying, increase length and weight of intestinal tract, 
increase mortality rates and depress nutrient utilization (Vohra and Kratzer, 1964; Holt 
et al, 1979; Ray et al, 1982; Patel et al, 1982). Daskiran et al, 2004 reported that the 
negative effects of guar gum inclusion were alleviated by the supplementation of β-
mannanase enzyme and with the enzyme, performance was equal to the control groups. 
Also, supplementing diets with mannanase enzyme resulted in improved feed utilization. 
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Partially hydrolyzed guar gum was prepared by partial hydrolysis of the mannan 
backbone of guar gum with β-1,4-endomannanse (Takahashi et al, 1993). Partially 
hydrolyzed guar gum has been reported to decrease the incidence of bacterial 
translocation (migration of bacteria from intestinal tract to lymph nodes) in mice (Wells 
et al, 1992), to promote growth of intestinal mucosal cells, to moderate diarrhea, 
constipation, to reduce cecal pH, to reduce Staphylococcus frequency and to improve the 
growth of cecal Bifidobacterium and Lactobacillus in rats (Takahashi et al, 1995). In a 
human volunteer study conducted by Tsuda et al, (1998) partially hydrolyzed guar gum 
has also been reported to reduce the blood glucose levels after sucrose intake. It has been 
reported that intact guar gum has more detrimental effects compared with partially 
hydrolyzed guar gum (Takahashi et al, 1995). 
Partially hydrolyzed guar gum has been demonstrated to improve intestinal 
microflora balance in humans (Okubo et al, 1994) and in animals (Takahashi et al, 
1995). With respect to poultry, Administration of partially hydrolyzed guar gum at 
0.025% in young laying hen diets resulted in significant increase in Bifidobacterium spp. 
and Lactobacillus spp. numbers and inhibition of the Enterobacteriaceae (Ishihara et al, 
2000). Interestingly, this inhibitory effect was not observed in diets containing 0.05 or 
0.1% partially hydrolyzed guar gum. As Salmonella enteritidis belongs to 
Enterobacteriaceae, the authors suggested that enzyme supplementation may decrease 
Salmonella enteritidis counts.  
Dietary supplementation of carob bean gum galactomannans in chicken diets 
reduced the populations of Salmonella in a challenge model, but not without adverse 
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effects on performance and nutrient digestibility (Vila et al, 2012). Vila et al, (2012)  
suggested adding β-mannanase to counteract the effects of galactomannan. Vila et al, 
(2012) also demonstrated that oligomeric mannoses are more efficient than monomeric 
D-mannose in inhibiting Salmonella infection in chickens. In a recent in-vitro study 
conducted by Badia et al, (2012), the β-galactomannan was shown to inhibit association 
of Salmonella enterica with porcine intestinal epithelial cells and to modulate immune 
response. D-mannose or mannose residues obtained from Yeast Cell Wall (YCW) are 
also known to be effective in reducing the colonization of Salmonella spp. (Oyofo et al, 
1989a; Spring et al, 2000).  
The gastrointestinal tract of chickens harbors a diversified microflora. The gut 
microflora acts as an efficient barrier to protect against invasion of pathogens and 
stimulates host defensive mechanisms. As gut microflora plays a major role in 
maintaining host health, altering the composition of gut microbiota in a positive way is 
increasingly being considered of value. Digestive microbial populations can be altered 
by changes in the diet. The modulation of intestinal microflora to protect host health is 
possible with the dietary supplementation of both probiotics and prebiotics.  
To my knowledge, no study to date has evaluated the effects of guar gum 
galactomannans on intestinal histomorphology and microbial ecology in broilers. This 
study was designed to evaluate the effects of guar gum galactomannans supplemented 
diets with and without β-galactomannanase enzyme on starting broiler performance in 
terms of growth, feed efficiency, digestibility, intestinal histomorphology and microbial 
ecology. The hypothesis of this study is that the prebiotic properties of enzyme (β-
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galactomannanase) supplemented guar gum galactomannans are equivalent to those of 
YCW-MOS in starting broilers. 
MATERIALS AND METHODS 
Experimental design and general procedure 
 A total of 144 newly hatched Ross 308 strain broiler chicks were purchased from 
Sanderson farms, Bryan, TX and randomly distributed over one Petersime battery 
brooder unit among four dietary treatments with six replicates of six birds per pen (24 
pens, 4 treatments, 6 replicates, 6 birds per pen). A basal industrial type corn soy based 
broiler starter diet was prepared (Table 4-1). The basal diet was divided into 4 equally 
sized portions and 3 batches were supplemented with one of the three additives. Chicks 
were assigned to one of the following dietary treatments: 1) negative control: a basal 
industry type broiler starter diet, 2) positive control YCW-S: the basal diet supplemented 
with 500 ppm of YCW-MOS Safmannan® (LeSaffre feed additives, Milwaukie, WI) 3) 
GG: the basal diet supplemented with 500 ppm of guar gum galactomannans (Spectrum 
Chemical MFG. Corp, Gardena, CA), and 4) GGE: the basal diet supplemented with 500 
ppm guar gum galactomannans along with one gram of Mannanase Guar® 
(AGRIaccess, Bothwell, WA). Mannanase guar® (β-galactomannanase, 1000 units/gm 
and cellulose 500 units/gm minimum activities) is a targeted exogenous enzyme blend 
designed to hydrolyze the β-galactomannan in residual guar gum of guar meal. The 
composition of guar gum is given in the Table 4-2. 
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Table 4-1: Composition and nutrient content of broiler starter diets used in this 
study 
 
INGREDIENT PERCENTAGE 
Corn 58.434 
Soybean meal 48% 34.493 
Dl-Met 98% 0.231 
Lysine HCl 0.177 
AV Fat, blended 2.755 
Limestone 1.561 
Mono-Dicalcium Phosphate 1.537 
Salt 0.512 
Trace minerals premix
1 
0.050 
Vitamin premix
2 
0.250 
CALCULATED NUTRIENT CONTENT (%)  
Protein 22.00 
ME (Kcal/Kg) 3050.00 
Crude fat 5.32 
Crude fiber 2.63 
Calcium 0.95 
AV Phosphate 0.71 
Sodium 0.22 
Methionine  0.56 
Lysine 1.31 
 
1 
Trace minerals premix added at this rate yields: 27.50 mg sulphur, 150 mg manganese, 
16.50 mg iron, 1.70 mg copper, 125.50 mg zinc, 0.25 mg selenium, 1.05 mg iodine, and 
0.84 mg molybdenum per kilogram diet. 
2 
Vitamin premix added at this rate yields: 11,023 IU vitamin A, 46 IU vitamin E, 3,858 
IU vitamin D3, 1.47 mg menadione, 2.90 mg thiamin, 5.80 mg riboflavin, 20 mg 
pantothenic acid, 0.55 mg biotin, 1.75 mg folic acid, 478 mg choline, 16.50 μg Vitamin 
B12, 46.00 mg niacin, and 7.20 mg pyridoxine per kilogram of diet. 
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Table 4-2: Composition of guar gum galactomannans supplemented in the 
study
1 
 
Compound Percent 
Galactomannans Minimum 70% 
 Maximum limits 
Acid insoluble matter 7.0% 
Total ash 1.5% 
Lead 2 mg/kg 
Loss on drying 15% 
Protein 10% 
 
1
Composition determined by Spectrum Chemical MFG. Corp (Gardena, CA). 
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Birds were provided ad libitum access to water and feed. On day 18, titanium 
dioxide (an indigestible marker) was added to all the experimental diets at the rate of 
0.3%. Temperature in room the brooder room was thermostatic and twenty-four hour 
lighting was provided. Each brooder pen contained a heat lamp for supplemental heat as 
required. No concomitant drug therapy was used during the study. Daily observations 
were made with regard to general flock condition, temperature, lighting, water, feed, and 
unanticipated events in the house. Pens were also checked daily for mortality. Pen was 
the unit of measure for performance phase of this experiment. Birds dying within the 
first 3 days of the study were replaced. Bird weights and feed consumption (grams) by 
pen were recorded at day 0, 7, 14 and 21 days of the experiment.  
Performance variables evaluated in this study were body weight per bird (BW), 
weight gain per bird (WG), total feed consumption (FC), feed conversion ratio (FCR), 
Productivity Index (PI), and percent mortality rate (MORT). Productivity index is 
calculated using the following mathematical formula:   
PI = (100-MORT) x (BW/1000)/Bird age/FCR x 100 
Intestinal histomorphology 
 On day 22, all birds were euthanized and six birds per treatment were randomly 
selected to collect small intestine portions. Birds were opened, small intestines were 
removed, and three sections throughout the small intestine were dissected. Cross-
sections were excised 2-3 cm anterior to the distal end of each of the three sections – 
duodenum, jejunum (between the distal portion of duodenal loop and Meckel’s 
diverticulum) and ileum (between Meckel’s diverticulum and anterior portion of ileo-
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caecal junction). Each cross-section was rinsed with isotonic saline (0.9% NaCl) to 
remove intestinal contents from the intestinal lumen, the serosal surface was labeled with 
indelible ink for identification purposes and fixed in 10% neutral buffered formalin. The 
fixed samples were embedded in paraffin and the samples were sent to the Texas 
Veterinary Medical Diagnostic Laboratory for the slide preparation. Slides containing 
intestinal sections stained with hematoxylin and eosin (H&E) were used to evaluate 
histomorphology of the small intestine. 
 Parameters measured were the height of intestinal villus and crypt depth. 
Histological images taken with Zeiss Axioplan microscope were examined by 
AxioVision LE software (Carl Zeiss Microscopy GmbH, Jena, Germany). The villus 
height was measured in microns from villus tip to the bottom, excluding crypt. A total of 
9 measurements were taken from each intestinal region per bird thus yielding 54 
observations per treatment group. The average of these 9 measurements per each 
intestinal region was used in statistical analysis.  
Apparent ileal energy digestibility 
 Intestinal contents from the ileum were collected from one bird per pen yielding 
a total of 6 birds per treatment. All the ileal samples and two feed samples from each 
treatment were dried at 100
0
 C for 24 h in a forced draft drying oven, cooled, finely 
ground and stored in a desiccator for further analysis. Gross energy content of the feed 
and ileal contents was calculated by bomb calorimetry in a Parr Adiabatic bomb 
calorimeter (Moline, Illinois). Titanium dioxide (indigestible marker) content of dietary 
treatments and ileal contents was measured by spectrophotometry as previously 
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described by Short et al, (1996). The Gross Energy (GE) values of ileal digesta were 
calculated using the following formula 
GE ileum digesta = GE concentration in digesta x diet marker concentration (mg/kg) 
                                                                                digesta marker concentration (mg/kg) 
GE values are expressed as mg/Kcal/Kg dry matter intake. 
Apparent ileal digestibility of the dietary treatments was calculated using the following 
formula:  
Apparent ileal GE digestibility = GE in diet-GE in ileum digesta 
             GE in diet 
Statistics: Data were analyzed by ANOVA using the GLM procedure with 4 treatments. 
Significant differences among treatment means were separated using Duncan’s multiple 
range test at P < 0.05.  
Intestinal microbial ecology 
 Distal ileal and cecal contents from 5 birds per treatment from different replicates 
were aseptically collected into sterile tubes containing 2.25 ml of Butterfield’s buffer 
within 10 minutes after chickens were euthanized and contents were kept at 4
0 
C until 
frozen and stored at -20
0 
C. Ileal and cecal pH values were measured for each sample 
before processing them for DNA isolation. Bacterial DNA from both ileal and cecal 
samples were isolated from 1 ml of each sample (QIAamp Mini DNA Kit, Qiagen Inc., 
Valencia, CA) by following the method as described in the kit. Samples were 
centrifuged at 8000 x g for 10 minutes and pellets were suspended in 180 µl of TRIS 
EDTA Triton solution containing 20 mg/ml lysozyme (Sigma Chemical Company, St. 
Louis, MO) and incubated at 37
0 
C for 30 min. Isolated DNA samples were checked for 
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quantity and quality (NanoDrop ND-1000, Thermo Scientific, Wilmington, DE) are 
stored at -70
0
 C. Sample DNA from each treatment group (5) was pooled (50 ng each) to 
carry out PCR. This combined sample from several birds greatly reduces between group 
variation and allows for a clearer comparison of treatment differences. Amplicons were 
visualized by running on a 2% E-gel (Life Technologies, Grand Island, NY) for 30 min 
at 60 V. No PCR product or DNA was observed in any of the ileal DNA samples. These 
negative samples were again subjected to PCR by doubling the amount of pooled DNA 
(100 ng) and no ileal amplicons were noticed. So, DGGE (Denaturing Gradient Gel 
Electrophoresis) was carried out only with pooled cecal samples.  
Bacterial diversity of ceca was investigated by performing DGGE of 16S rRNA 
gene PCR amplicons as described by Muyzer et al, (1993) and as modified by Hume et 
al, (2003). Primers (Integrated DNA Technologies, Inc., Coralville, IA) (12.5 pmole of 
each per reaction mixture; primer 2, 5′-ATTACCGCGGCTGCTGG-3′, and primer 3 
with a 40-base G-C clamp (Sheffield et al, 1989; Muyzer et al, 1993), 5′-
CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGCCTACGGGAG
GCAGCAG-3′) were mixed with Jump Start Red-Taq Ready Mix (Sigma Chemical 
Company, St. Louis, MO) according to the kit instructions, 250 ng of pooled (50 ng for 
each of the 5 samples in each treatment group) template DNA and 0.1% (wt/vol) BSA to 
increase PCR yields, and to stabilize the enzymes (Kreader, 1996). Amplifications were 
carried out in a PTC-200 Peltier Thermal Cycler (MJ Research Inc., Waltham, MA) 
using the following program: 1) denaturation at 95
o 
C for 2 min; 2) subsequent 
denaturation at 94
0
C for 1 min; 3) annealing at 67
0 
C for 45 seconds, -0.5
0 
C per cycle 
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(touchdown - annealing temperature is decreased by –0.50 C every second cycle to enrich 
for products containing correct matches between primers and template, and to minimize 
spurious priming during amplification) (Don et al, 1991) 5) repeat stets 2 to 4 for 17 
cycles; 6) denaturation at 94
0 
C for 1 min; 7) annealing at 58
0 
C for 45 seconds; 8) 
extension at 72
0 
C for 2 min; 9) repeat steps 6 to 8 for 12 cycles; 10) extension at 72
0 
C 
for 30 min; 11) 4
0 
C final.  
Polyacrylamide gels (8% (vol/vol) acrylamide-bisacrylamide ratio 37.5:1 (Bio-
Rad Laboratories, Richmond, CA.)) were cast with urea-deionized formamide gradient 
of 35 to 60%; 100% denaturing acrylamide was 7 M urea and 40% deionized 
formamide. Amplified PCR samples were mixed with an equal volume of 2x loading 
buffer [0.05% (wt/vol) bromophenol blue, 0.05% (wt/vol) xylene cyanol, and 70% 
(vol/vol) glycerol] and 5.6 µl were loades in each sample well (25-well comb; 4 
mm/well). Equal volumes of 6 reference strains were mixed. Equal volumes of (3 µl)   of 
the reference strains and 2x DGGE loading dye were mixed and added to 3 wells. Gels 
were placed in a DCode Universal Mutation Detection System (Bio-Rad Laboratories, 
Richmond, CA.) for electrophoresis in 1x TAE (prepared from 50x stock running buffer) 
at 59
0 
C for 17 hours at 60 V. Gels were stained in 300 ml of 1x TAE and 30 µl of SYBR 
Green (Sigma Chemical Company, St. Louis, MO). Relation among fragment patterns 
was determined using Molecular Analysis Fingerprinting Software, version 1.6 (Bio-Rad 
Laboratories, Herculus, CA). Band patterns in the dendrogram were analyzed by 
similarity coefficient percentage.  
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RESULTS 
 No significant differences were observed in production variables for any of the 
dietary treatments tested (Table 4-3). Broilers receiving the diets supplemented with GG 
exhibited significant reduction in apparent ileal energy digestibility compared to control. 
Broilers receiving the dietary additives YCW-S and GGE did not differ significantly in 
terms of apparent ileal energy digestibility values. None of the treatments showed 
significant difference in ileal and cecal pH values (data not shown). 
Results of intestinal histomorphology are shown in Table 4-4. Broilers receiving 
GG in their diet had significantly reduced villus height in all the three intestinal regions 
and, increased crypt depth in the jejunum. This negative effect has been counterbalanced 
by the addition of exogenous enzyme to the diet. Broilers receiving GGE had overall 
intestinal villus height equal to or more than that of either the YCW-S or control group. 
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Table 4-3: Effect of GG and GGE on performance and apparent ileal energy digestibility of the birds at 22 days of age 
 
Treatment n BW* WG* FC* FCR PI AIED** 
Control 6 776 733 1052 1.43 258 71.6
a 
YCW-S
1 6 763 719 996 1.39 262 67.0
ab 
GG
2 6 778 740 1028 1.39 256 56.5
b 
GGE
3 6 792 748 1041 1.39 271 64.1
ab 
PSEM***  19.38 20.08 24.83 0.02 9.70 3.81 
P-Value   0.727 0.759 0.437 0.242 0.683 0.074 
 
1
Diets supplemented with 500 ppm YCW-MOS Safmannan®. 
2
Diets supplemented with 500 ppm guar gum galactomannans. 
3
GG diets containing an exogenous enzyme Mannanase Guar®. 
a,b 
Means within a column with no common superscript differ significantly (P<0.05). 
*Final body weight, weight gain and total feed consumption are given in grams (per bird). 
**Apparent ileal energy digestibility. 
***Pooled Standard Error Mean. 
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Table 4-4: Histomorphology of the different portions of the small intestine at 22 days of age 
 
  Duodenum Jejunum Ileum 
Treatment n Villus height, 
µm 
Crypt 
depth, µm 
Villus height, 
µm 
Crypt 
depth, µm 
Villus height, 
µm 
Crypt 
depth, µm 
Control 6 767.2
b 
50.5
b 
699.7
a 
59.3
bc 
513.8
b
 70.8
bc 
YCW-S
1 6 814.0
a 
69.0
a 
718.8
a 
66.3
b 
502.7
b
 89.5
a 
GG
2 6 686.3
c 
56.7
b 
576.5
b 
100.
a 
465.7
c 
76.5
b 
GGE
3 6 835.7
a 
68.0
a 
705.8
a 
57.7
c 
588.0
a 
65.7
c 
PSEM*  12.63 2.04 12.52 3.78 9.66 2.15 
P Value <  0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 
 
1
Diets supplemented with 500 ppm YCW-MOS Safmannan®. 
2
Diets supplemented with 500 ppm guar gum galactomannans. 
3
GG diets containing an exogenous enzyme Mannanase Guar®.  
a,b,c 
Means within a column with no common superscript differ significantly (P<0.05). 
*Pooled Standard Error Mean. 
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Amplicon profiles for cecal bacteria are shown in Figure 4-1. Comparisons of 
cecal microbial profiles for all treatment groups resulted in two main groups with 92.6% 
similarity suggesting somewhat different microbial populations. Patterns from control 
and GG treated chicks grouped together with 94.7% similarity coefficient indicating 
slightly different populations between these two treatments. Microflora patterns from 
YCW-S and GGE treatments grouped together with 95.6% similarity coefficient. More 
than 95% similarity coefficient in band patterns indicates that the microbial populations 
examined are essentially identical. In the present study, it is revealed that the cecal 
microbial populations in broilers receiving either the YCW-S or GGE are identical. The 
cecal microbial populations from GG treated and negative control birds are somewhat 
similar with 94.7% relative coefficient. 
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Figure 4-1: Denaturing gradient gel electrophoresis gel of cecal bacterial 16S amplicon band patterns from broiler chicks 
receiving dietary additives at 22 days of age.  
Relative similarity of band patterns is indicated by their grouping on the dendrogram and the percentage coefficient.  
C1 - Ceca - Control. 
C2 - Ceca - YCW-S (Diets supplemented with 500 ppm YCW-MOS). 
C3 - Ceca - GG (Diets supplemented with 500 ppm guar gum galactomannans). 
C4 - Ceca - GGE (GG diets containing the exogenous enzyme Mannanase Guar®). 
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DISCUSSION 
Non-starch polysaccharides induce both physiological and morphological 
changes in the digestive system. NSP’s increase intestinal viscosity and reduce the 
digestion and absorption of nutrients (Annison et al, 1995; Smits and Annison, 1996; 
Choct et al, 2001). It was expected that dietary guar gum would reduce the productive 
performance of the birds and these negative effects would be counterbalanced by the 
addition of the enzyme cocktail (Mannanase Guar®)to break down mannose back bone 
of guar gum galactomannans. However, neither dietary guar gum galactomannans alone 
nor with enzyme supplementation had any significant effect on the production 
parameters evaluated. This may be due to the low level of guar gum (500 ppm or 0.05%) 
tested in this investigation. Dietary guar gum is known to reduce body weight and 
weight gain in broilers when included at 2% level in broiler starter diets (Vohra and 
Kratzer, 1964; Ray et al, 1982; Daskiran et al, 2004).  
Similarly, when broilers were fed diets containing 10% copra meal (containing a 
NSP galactomannan similar to guar gum), decreases in weight gain, feed intake and  
nutrient digestibility were observed (Sundu et al, 2006). Further, this decrease was 
proportional to the amount of copra meal in the diet. These negative effects were 
alleviated partially by supplementing copra meal diets with an enzyme cocktail 
mannanase, galactosidase, glucanase, and cellulases, thus resulting in increased weight 
gain, decreased FCR and improved nutrient digestibility. Galactomannans are cell wall 
components of most legumes (Reid, 1985) and also found in soybean in small quantities 
(Ward and Fodge, 1996). Therefore, appropriate exogenous enzyme supplementation 
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may improve nutrient utilization in regular corn soy based diets (Daskiran et al, 2004; 
Zou et al, 2006) as well as other diets not necessarily based on soybean meal 
Broilers receiving GG diets exhibited decreased apparent ileal digestible energy 
and enzyme supplemented diets did not show an improvement in apparent ileal 
digestible energy. No significant difference in apparent ileal energy digestibility was 
observed among broilers receiving YCW-S and GGE diets. Daskiran et al, (2004), 
reported that the broiler diets containing 1% and 2% guar gum produced a significant 
reduction in dietary metabolizable energy and net energy gain, and supplementation of 
guar gum diets with 0.05% β-D-mannanase partially reduced those negative effects. The 
viscous nature of guar gum is responsible for reduced digestibility and nutrient 
absorption, which occurs by delayed gastric emptying, impairing the action of digestive 
enzymes and reducing the contact of nutrients with the absorptive surface (Read, 1986).  
Geier et al (2009) did not observe any significant differences in apparent 
metabolizable energy and ileal digestible energy among tested dietary treatments, 
control, AGP (Zinc bacitracin 50 ppm), MOS (Bio-Mos, Alltech Inc., Nicholasville, KY) 
at 5 g per kg and FOS (Fibrulose F97,Cosucra Group, Warcoing, Warcoing, Belgium) at 
5 g per kg (5000 ppm) of diet. The dietary addition of MOS did not affect the 
digestibility of starch, protein and fat in 3 week old broilers (Yang et al, 2008). In the 
present study, apparent ileal energy digestibility of broilers receiving 500 ppm YCW-S 
was not significantly different from the negative control.  
The results of the current study indicated that broilers receiving GG diets 
exhibited reduced intestinal villus height whereas broilers receiving GGE diets showed 
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increased intestinal villus height. Increased intestinal villus height offers a greater 
surface area for absorption and should improve nutrient utilization. Dietary inclusion of 
MOS is believed to improve gut health by increasing villus height, uniformity and 
intestinal integrity (Santin et al, 2001; Loddi et al, 2002; Zhang et al, 2005; Baurahoo et 
al, 2007). In this study, the YCW-S treated broilers showed significant improvement in 
duodenal villus height, with no effect in jejunum or ileum. However, GGE treated group 
displayed intestinal villus height equal to or better than positive control YCW-S treated 
birds.   
In this investigation, no significant differences were observed in the ileal pH and 
cecal pH values among any of the dietary treatments. Yang et al, (2008) did not observe 
any difference in cecal pH of YCW treated birds, but ileal pH values were significantly 
higher compared to the control when wheat barley diets were fed. The inconsistency in 
the results of various reports in the literature may be due to the differences in nutrient 
composition of diets, rearing conditions and other environmental factors.  
The PCR-based DGGE technique is useful for determining the microbial 
community shifts induced by various dietary treatments (Hume et al, 2003). Microbial 
ecology results of the present study indicated that the cecal microbial populations from 
the positive control (YCW-S) and GGE diets grouped together with a 95.6% relative 
similarity coefficient suggesting identical microbial populations in these two treatment 
groups. Dietary YCW are known to reduce pathogenic bacterial load and improve 
beneficial bacterial colonization in broilers (Spring et al, 2000; Baurhoo et al, 2007). 
Very similar microbial patterns were observed in YCW-S and GGE treated groups. 
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Therefore, enzyme supplemented guar gum galactomannans may have a beneficial effect 
on host health. The microbial shifts in the cecum observed in the present study did not 
have any effect on the growth rate and feed conversion ratio. This finding is in consistent 
with the results reported by Geier et al, (2009) where significant overall intestinal 
(combined jejunum, ileum and cecum microbial populations) microbial shifts observed 
with the feeding of YCW (Bio-Mos, Alltech Inc., Nicholasville, KY) did not result in 
improved performance in broilers. Intestinal microbial communities can modify energy 
metabolism by exhibiting a buffering or a counter-productive action on the utilization of 
energy in chickens (Muramatsu et al, 1994).  
GGE treated birds exhibited intestinal function equal to the positive control birds, 
and, microbial patterns from these two groups are identical, whereas GG treated birds 
poorly performed compared to the negative control. Therefore, GGE may have a positive 
effect on intestinal microbiota balance and potentially effective in preventing on some 
pathogenic microbial colonization. The results indicated β-galactomannanase 
supplemented as Mannanase Guar® may be effective in alleviating some negative 
effects associated with the feeding of guar meal.  
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CHAPTER V 
SUMMARY AND CONCLUSIONS  
Previous researchers have described YCW products as “MOS” in their reports, 
which is not technically correct. YCW products are a rich source of MOS as 
mannoproteins but YCW also contains high concentrations of β-glucans. The first study 
(chapter 3) of this research evaluated the efficacy of yeast cell wall products containing 
mannanoliogsaccharides on starting broiler performance. Clostridium perfringens 
infection was experimentally induced in broiler chicks under immune suppression to 
better assess the prebiotic potential of these feed additives. The second study (chapter 4) 
evaluated the prebiotic efficacy of guar gum galactomannans supplemented with an 
exogenous β-galactomannanase enzyme (Mannanase Guar®) in starting broilers. 
YCW-MOS supplemented diets resulted in improved performance with a 
decrease in FCR. Both of the YCW-MOS products obtained from two sources 
(Safmannn® – bakers yeast; Pronady® – brewers yeast) produced a significant 
improvement in body weight with reduced FCR compared to the control birds. However, 
no difference between the two sources of the YCW-MOS additives was detected. 
Interestingly, a blend of these two products appears to be the best YCW-MOS to 
promote growth rate. Broilers (3-week old) receiving the blend of YCW-MOS products 
in their diets showed an overall improvement of 15% in body weight, and 10% reduction 
in FCR with higher productivity index compared to the control birds not receiving any 
YCW-MOS product.  
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Broilers treated with 125, 250, 375 or 500 ppm of YCW-MOS additive exhibited 
lower FCR compared to the control birds. Broilers receiving 250 ppm YCW-MOS 
showed a peak response in body weight when body weight was fitted to dose in second 
order regression line. YCW-MOS additive at 375 ppm produced a higher productivity 
index. This investigation also suggests that the optimal level of YCW-MOS products 
(both brewers and bakers yeast) as growth promoting feed additives in starting broiler 
diets is approximately 250 ppm.  
These findings are commercially important as previous literature suggested an 
optimal dose of more than 500 ppm or 1000 ppm YCW-MOS additive in starting 
broilers. This is the first kind of investigation which evaluated different sources and a 
blend of YCW-MOS products. Supplementation of YCW-MOS additives in broiler 
starter diets improved both growth rate and feed efficiency. Based on the results of this 
investigation, LeSaffre feed additives (Milwaukie, WI) has developed a new product 
called CWall® (Appendix 4) to improve growth rate in poultry. YCW-MOS products 
may be considered as potential alternatives to traditional antibiotic growth promoters in 
poultry feeds. 
The presence of non-digestible carbohydrates in poultry diets influences nutrient 
utilization. Galactomannan, a non-starch polysaccharide naturally occurring in several 
plant legumes is known to depress nutrient utilization by increasing the viscosity of 
intestinal contents. Adding appropriate exogenous enzymes to reduce the negative 
effects of some NSPs is a common practice in poultry feeding. These enzymes improve 
digestibility of the polysaccharides, otherwise not digested by the host system. 
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Galactomannan gum obtained from the plant legume guar may be considered for 
prebiotic functions.  
In the second study (chapter 4) of this research, prebiotic efficacy of guar gum 
galactomannans supplemented with an exogenous β-galactomannanase enzyme 
(Mannanase Guar®) was evaluated in starting broilers. This investigation indicated that 
neither guar gum nor enzyme had any effect on the production parameters. The guar 
gum galactomannans (GG) inclusion significantly reduced apparent ileal energy 
digestibility values compared to the control. Mannanase Guar® supplementation did not 
significantly affect apparent ileal energy digestibility.  
Broilers treated with GG diets showed a reduction in intestinal villus height 
compared to the negative control. Broilers receiving the positive control YCW 
Safmannan® and enzyme supplemented GG showed overall improvement in intestinal 
function as evident by increased villus height and reduced crypt depth. Increased villus 
height is thought to offer a greater surface area for nutrient absorption thus resulting in 
increased nutrient utilization.  
Comparison of the cecal microbial profiles for all treatment groups resulted in 
two main groups with 92.6% similarity. Band patterns from control and guar gum treated 
chicks grouped together with a 94.7% similarity coefficient and microflora patterns from 
YCW Safmannan and enzyme supplemented GG treatments grouped together with a 
95.6% similarity coefficient. The cecal microbial populations from Mannanase Guar® 
supplemented GG diets and the positive control YCW Safmannan supplemented diets 
were essentially identical.  
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YCW-MOS additives are known to reduce pathogenic bacterial load and improve 
beneficial bacterial colonization in broilers. Identical microbial patterns were observed 
in YCW and enzyme treated groups in this study. Therefore, enzyme supplemented GG 
may have a beneficial effect on host health.  
Mannanase Guar® supplemented GG diets exhibited prebiotic properties by 
improving intestinal function and altering intestinal microbiota. The presence of residual 
guar gum in guar meal is responsible for limited use of protein rich guar meal in poultry 
diets. The enzyme cocktail (Mannanase Guar®)  evaluated in this study may be effective 
in reducing the detrimental effects associated with guar gum inclusion in poultry diets 
suggesting a potentially cost effective alternative to traditionally used growth promoting 
antibiotics. Guar gum is also generally known to improve pellet quality suggesting a 
possible dual benefit in pelleted poultry diets, when used in combination with an 
appropriate exogenous enzyme to reduce the negative viscosity effect of this non starch 
polysaccharide. 
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APPENDIX 
 
 
 
SAFMANNAN® 
 
A Yeast-derived source of Mannanoligosaccharides 
 
PRODUCT CODE:45335 
 
 
PRODUCT INFORMATION SHEET 
 
 
 
Description:   Safmannan is a source of Mannanoligosaccharides (MOS) derived from 
primary inactivated yeast (Saccharomyces cerevisiae) for use in rations for poultry, 
swine, cattle, and fish. 
 
Ingredient Statement:   Dried yeast cell wall 
 
 
 
Chemical Composition: 
 
Moisture               2-3%  
Dry Matter        97-98%           
Proteins             14-17%                      
Fat                     17-23%                        
Ash                    3-5%                        
Mannans           22-24%                         
Beta-glucans, total   24-26%                  
 
 
 
Physical Composition: 
 
Appearance                             Light tan powder 
Aroma                                     Mild yeasty 
Flavor                                     Mild yeasty, slight metallic note 
Mouthfeel                               Chalky, drying 
 
Packaging:                    25 kg (55 lb) poly-lined kraft bag
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SAFMANNAN® CODE 45335 
 
Approximate analysis of vitamins, minerals, and amino acids (essential amino acids are 
underlined). 
 
Vitamins 
Vitamin A 
Mg/100g 
100 IU 
Minerals 
Calcium 
Mg/100g 
154 
Amino Acids 
Alanine 
Mg/g 
8.2 
Niacin 2.13 Copper 8 Ammonia 2.6 
Riboflavin (B2) 0.1 Iron 4.6 Arginine 5.9 
  Phosphorus 862 Aspartic Acid 9.9 
  Potassium 377 Glutamic Acid 13.8 
  Sodium 59 Glycine 5.0 
 Histidine 2.7 
Isoleucine 5.5 
Leucine 9.1 
Lysine 9.0 
Methionine 1.1 
Phenylalanine 4.9 
Proline 4.3 
Serine 7.7 
Threonine 9.0 
Tyrosine 4.1 
Valine 6.1 
 
Fatty Acid Composition 
C16 (palmitic acid) 
 
8-12% 
 
C16-1 (palmitoleic acid) 40-50% 
C18 (stearic acid) 1-4% 
C18-1 (oleic acid) 30-40% 
C18-2 (linoleic acid) 3-5% 
C18-3 (linolenic acid) 1-3% 
 
Phospholipid Composition  
 
Phosphatidyl choline 
 
40-50% 
Phosphatidyl inositol 15-30% 
Phosphatidylserine 7-10% 
Phosphatidylethanolamine 5-6% 
Lisophosphatidylcholine 0-13% 
 
Specification Total Bacteria Mold 
Coliform E. coli Salmonella 
 
Guarantee 
2000/g maximum 
10/g maximum 
< 10 CFU/g Neg /10g Neg/1500g 
 
Typical Analysis 
<10 - 100/g 
<10/g 
< 10 CFU/g Neg / 10g 
Neg/1500g 
Storage: Store under cool, dry storage conditions. The product is stable for 48 Months. 
 
The information herein is true and accurate to the best of our knowledge, however, this data sheet is not to be considered as a 
guarantee expressed or implied, or as a condition of sale of this product. 
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Pronady 500
TM 
 
Product Information Sheet 
 
 
General Description 
 
Pronady 500 is a source of Mannanoligosaccharides (MOS) derived from inactivated 
brewer’s  yeast  (Saccharomyces  cerevisiae)  for  use  in  rations  for  poultry and  
young livestock. 
 
Chemical Composition 
 
Moisture 
 
 
 
3-5% 
Dry matter 95-97% 
Proteins 32-40% 
Fats 3-7% 
Phosphorus 1-2% 
Mannans 12-16% 
Beta-glucans, total 24-28% 
Ash 3-5% 
 
 
Physical Composition  
 
Color 
Smell 
Impurities and defects 
 
Cream to tan 
Typical of yeast, beer 
No evidence of extraneous or foreign material 
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Microbiological Composition 
 
Coliforms per gram                              negative  
Salmonella                        negative  
Staphylococcus                                    < 1 
 
 
 
Typical Usage Level 
 
1 to 2 pounds per ton of feed. 
500 to 1,000 grams per metric ton of feed. 
 
 
 
Packaging 
 
Fifty-five pound net weight multi-wall Kraft bags with polyethylene liner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The information contained herein is, to the best of our knowledge, correct. The data outlined and the statements made are intended only as a source of 
information. No warranties, expressed or implied, are made. On the basis of this information, it is suggested that you evaluate the product on a 
laboratory scale prior to use in a finished product. 
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BIOSAF® 
 
Product Information Sheet 
  
 
 
General Description 
 
BIOSAF® is a concentrate of live Saccharomyces cerevisiae yeast cells.  This strain 
(SC47) is carefully grown to yield maximum uniformity and consistency. BIOSAF is 
designed to be incorporated in pelleted feeds due to a unique natural coating technology 
that provides excellent resistance to heat shock during the pelleting process. Each batch 
produced  is  thoroughly tested to  insure conformity to microbiological, physical, and 
chemical standards. 
 
 
 
Chemical Composition 
 
Moisture 
 
 
 
6.5-8.5% 
Dry material 92-94% 
Proteins 40-46% 
Fats 4-7% 
Carbohydrates 40-50% 
Ash 5-7% 
 
 
Physical Composition  
 
Color Smell Particle size 
Impurities and defects 
 
Tan 
Typical of yeast 
Granularsphere:  2-3 mm. 
No evidence of extraneous or foreign material 
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BIOSAF®                                                                                                                                                                                                                                                       
 
 
 
Microbiological Composition 
 
Live yeast cell count per gram           10 Billion CFU minimum 
Coliforms per gram                            Negative 
Salmonella                                          Negative in 25 g of BIOSAF  
 
Typical Usage Level 
 
0.1-0.3 percent of the total daily ration. 
 
 
 
Packaging 
 
BIOSAF® is sealed in 25-kilogram, multi-wall polyethylene-lined kraft bags to preserve 
activity and prevent loss of product during shipping and storage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The information contained herein is, to the best of our knowledge, correct. The data outlined and the statements made are intended only as a source of 
information. No warranties, expressed or implied, are made. On the basis of this information, it is suggested that you evaluate the product on a 
laboratory scale prior to use in a finished product 
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C Wall® 
 
A Yeast-derived source of Mannanoligosaccharides 
 
Product Code ------ 
 
Product Information Sheet 
 
General Description: C Wall is a source of Mannanoligosaccharides (MOS) derived 
from primary inactivated yeast (Saccharomyces cerevisiae) for use in rations for poultry, 
swine, cattle, fish, and companion animals. 
 
Ingredient Statement:          Yeast extract 
 
Chemical Composition: 
 
Moisture                                 3-5%  
Dry Matter                              95-97%  
Proteins                                  26-32%  
Fat                                          10-16%  
Ash                                         8-12%  
Mannans                                 17-22%  
Beta-glucans, total                  20-32% 
 
Physical Composition: 
 
Appearance                             Light tan to tan powder 
Aroma                                     Mild yeasty 
Flavor                                     Mild yeasty, slight metallic note 
Mouthfeel                               Chalky, drying 
 
Packaging:                   25 kg (55 lb) poly-lined kraft bag 
 
Storage: Store under cool, dry conditions. This product is stable for 48 months. 
 
 
The information herein is true and accurate to the best of our knowledge, however, this data sheet is not to be considered as a 
guarantee expressed or implied, or as a condition of sale of this product. 
